Chronic inflammatory disease epidemiology – Research group Johan Askling

Publications

All publications from group members

• Article: JOURNAL OF CROHN'S AND COLITIS. 2024;18(9):1371-1380

  Spondyloarthritis in First-Degree Relatives and Spouses of Patients with Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study from Sweden

  Shrestha S; Brand JS; Osooli M; Eriksson C; Schoultz I; Askling J; Jess T; Montgomery S; Olen O; Halfvarson J
• Article: GENERAL HOSPITAL PSYCHIATRY. 2024;89:23-31

  Association between inflammatory joint disease and severe or treatment-resistant depression: population-based cohort and case-control studies in Sweden

  Brenner P; Askling J; Hagg D; Brandt L; Stang P; Reutfors J
• Article: RHEUMATOLOGY. 2024;63(5):1221-1229

  Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis

  Sysojev AO; Saevarsdottir S; Diaz-Gallo L-M; Silberberg GN; Alfredsson L; Klareskog L; Baecklund E; Bjorkman L; Kastbom A; Rantapaa-Dahlqvist S; Turesson C; Jonsdottir I; Stefansson K; Frisell T; Padyukov L; Askling J; Westerlind H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(4):446-456

  Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study

  Exarchou S; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedren S; Lindstroem U; Turesson C; Jacobsson LTH; Askling J; Wallman JK
• Article: JOURNAL OF INTERNAL MEDICINE. 2024;295(3):313-321

  Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis

  Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
• Article: RHEUMATOLOGY. 2024;63(3):751-764

  Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

  Linde L; Ornbjerg LM; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Gudbjornsson B; Love TJ; Nordstrom DC; Yli-Kerttula T; Nekvindova L; Vencovsky J; Iannone F; Cauli A; Loft AG; Glintborg B; Laas K; Rotar Z; Tomsic M; Macfarlane GJ; Moller B; van de Sande M; Codreanu C; Nissen MJ; Birlik M; Erten S; Santos MJ; Vieira-Sousa E; Hetland ML; Ostergaard M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(3):277-287

  In early rheumatoid arthritis, anticitrullinated peptide antibodies associate with low number of affected joints and rheumatoid factor associates with systemic inflammation

  Pertsinidou E; Saevarsdottir S; Manivel VA; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Cornillet M; Serre G; Holmdahl R; Skriner K; Jakobsson P-J; Westerlind H; Askling J; Roennelid J
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;64:152313

  Infection outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study

  Simon TA; Suissa S; Skovron ML; Frisell T; Askling J; Michaud K; Pedro S; Strangfeld A; Meissner Y; Boers M; Hoffman V; Dominique A; Gomez A; Hochberg MC
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2024;64:152240

  Malignancy outcomes in patients with rheumatoid arthritis treated with abatacept and other disease-modifying antirheumatic drugs: Results from a 10-year international post-marketing study

  Simon TA; Suissa S; Boers M; Hochberg MC; Skovron ML; Askling J; Michaud K; Strangfeld A; Pedro S; Frisell T; Meissner Y; Dominique A; Gomez A
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2024;83(2):177-183

  Abatacept and non-melanoma skin cancer in patients with rheumatoid arthritis: a comprehensive evaluation of randomised controlled trials and observational studies

  Simon TA; Dong L; Suissa S; Michaud K; Pedro S; Hochberg M; Boers M; Askling J; Frisell T; Strangfeld A; Meissner Y; Khaychuk V; Dominique A; Maldonado MA
• Article: RMD OPEN. 2023;9(4):e003648

  Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden

  Bower H; Frisell T; di Giuseppe D; Delcoigne B; Lindstrom U; Turesson C; Chatzidionysiou K; Lindqvist E; Knight A; Forsblad-d'Elia H; Askling J
• Article: RMD OPEN. 2023;9(4):e003714

  Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study

  Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
• Article: RMD OPEN. 2023;9(4):e003630

  Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis

  Bower H; Frisell T; di Giuseppe D; Delcoigne B; Askling J
• Article: PSYCHOLOGICAL MEDICINE. 2023;53(15):7300-7308

  Maternal rheumatoid arthritis and risk of autism in the offspring

  Yin W; Norrback M; Levine SZ; Rivera N; Buxbaum JD; Zhu H; Yip B; Reichenberg A; Askling J; Sandin S
• Article: RMD OPEN. 2023;9(4):e003111

  Register-based observational study of associations between inflammatory remission, formal treatment targets and the use of disease-modifying antirheumatic drugs among patients with early rheumatoid arthritis

  Lindqvist J; Askling J; Lampa J
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;58(10):1028-1040

  Microscopic colitis and risk of incident rheumatoid arthritis: A nationwide population-based matched cohort study

  Bergman D; Roelstraete B; Sun J; Ebrahimi F; Askling J; Ludvigsson JF
• Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2023;21(12):3132-3142

  Increasing Risk of Lymphoma Over Time in Crohn's Disease but Not in Ulcerative Colitis: A Scandinavian Cohort Study

  Olen O; Smedby KE; Erichsen R; Pedersen L; Halfvarson J; Hallqvist-Everhov A; Askling J; Ekbom A; Sachs MC; Sorensen HT; Ludvigsson JF
• Article: RHEUMATOLOGY. 2023;62(10):3391-3399

  Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application

  Barbulescu A; Sjolander A; Delcoigne B; Askling J; Frisell T
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2023;58(7):692-703

  Increasing healthcare costs in inflammatory bowel disease 2007-2020 in Sweden

  Everhov A; Soederling J; Befrits G; Khalili H; Broems G; Neovius M; Askling J; Halfvarson JF; Ludvigsson J; Olen O; SWIBREG SG
• Article: RMD OPEN. 2023;9(3):e003027

  Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts

  Westerlind H; Glintborg B; Hammer HB; Saevarsdottir S; Krogh NS; Hetland ML; Hauge E-M; Tejada IM; Sexton J; Askling J
• Article: SCANDINAVIAN JOURNAL OF CLINICAL AND LABORATORY INVESTIGATION. 2023;83(5):330-335

  Calprotectin, a sensitive marker of inflammation, is robustly assessed in plasma from patients with early or established rheumatoid arthritis by use of different laboratory methods

  Hammer HB; Pedersen SL; Jonsson MKK; Mathsson-Alm L; Gehring I; Sexton J; Haavardsholm EAA; Askling J
• Article: EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2023;115:55-61

  How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway

  Delcoigne B; Provan SA; Kristianslund EK; Askling J; Ljung L
• Article: JOURNAL OF RHEUMATOLOGY. 2023;50(8):1009-1019

  One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

  Ornbjerg LM; Rugbjerg K; Georgiadis S; Rasmussen SH; Lindstrom U; Pavelka K; Yilmaz N; Favalli EG; Nissen MJ; Michelsen B; Vieira-Sousa E; Jones GT; Ionescu R; Relas H; Sanchez-Piedra C; Tomsic M; Geirsson AJ; van der Horst-Bruinsma I; Askling J; Loft AG; Nekvindova L; Direskeneli H; Iannone F; Ciurea A; Fagerli KM; Santos MJ; Macfarlane GJ; Codreanu C; Eklund K; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Rusman T; Ostergaard M; Hetland ML
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(4):374-384

  Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register

  Wallman JK; Alenius G-M; Klingberg E; Sigurdardottir V; Wedren S; Exarchou S; Lindstrom U; Di Giuseppe D; Askling J; Jacobsson LTH
• Corrigendum: NATURE COMMUNICATIONS. 2023;14(1):3923

  Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality (vol 14, 3453, 2023)

  Oddsson AR; Sulem P; Sveinbjornsson G; Arnadottir G; Steinthorsdottir VM; Halldorsson G; Atlason B; Oskarsson GO; Helgason H; Nielsen HS; Westergaard D; Karjalainen JA; Katrinardottir H; Fridriksdottir R; Jensson BB; Tragante V; Ferkingstad EA; Jonsson H; Gudjonsson S; Beyter D; Moore KHS; Thordardottir H; Kristmundsdottir S; Stefansson O; Rantapaeae-Dahlqvist S; Sonderby IE; Didriksen M; Stridh PA; Haavik J; Tryggvadottir L; Frei O; Walters GB; Kockum I; Hjalgrim H; Olafsdottir T; Selbaek G; Nyegaard M; Erikstrup C; Brodersen T; Saevarsdottir S; Olsson T; Nielsen KR; Haraldsson A; Bruun MT; Hansen TF; Steingrimsdottir TT; Jacobsen RL; Lie R; Djurovic S; Alfredsson L; Lopez de Lapuente Portilla A; Brunak SV; Melsted P; Halldorsson B; Saemundsdottir J; Magnusson OT; Padyukov L; Banasik K; Rafnar T; Askling J; Klareskog L; Pedersen OB; Masson G; Havdahl AA; Nilsson B; Andreassen O; Daly M; Ostrowski SR; Jonsdottir I; Stefansson H; Holm H; Helgason A; Thorsteinsdottir UF; Stefansson K; Gudbjartsson D
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(7):911-919

  Cancer risks with JAKi and biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis or psoriatic arthritis: a national real-world cohort study

  Huss V; Bower H; Hellgren K; Frisell T; Askling J; ARTIS G
• Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY (EJE). 2023;38(7):809-819

  Repurposing antidiabetic drugs for rheumatoid arthritis: results from a two-sample Mendelian randomization study

  Qin C; Diaz-Gallo L-M; Tang B; Wang Y; Nguyen T-D; Harder A; Lu Y; Padyukov L; Askling J; Hagg S
• Article: NATURE COMMUNICATIONS. 2023;14(1):3453

  Deficit of homozygosity among 1.52 million individuals and genetic causes of recessive lethality

  Oddsson A; Sulem P; Sveinbjornsson G; Arnadottir GM; Steinthorsdottir V; Halldorsson G; Atlason BO; Oskarsson G; Helgason H; Nielsen HS; Westergaard DA; Karjalainen J; Katrinardottir H; Fridriksdottir RB; Jensson B; Tragante VA; Ferkingstad E; Jonsson H; Gudjonsson S; Beyter D; Moore KHS; Thordardottir H; Kristmundsdottir S; Stefansson O; Rantapaa-Dahlqvist S; Sonderby IE; Didriksen MA; Stridh P; Haavik J; Tryggvadottir L; Frei O; Walters GB; Kockum I; Hjalgrim H; Olafsdottir T; Selbaek G; Nyegaard M; Erikstrup C; Brodersen T; Saevarsdottir S; Olsson T; Nielsen KR; Haraldsson A; Bruun MT; Hansen TF; Steingrimsdottir T; Jacobsen RLT; Lie R; Djurovic S; Alfredsson L; Lopez de Lapuente Portilla A; Brunak S; Melsted PV; Halldorsson B; Saemundsdottir J; Magnusson OT; Padyukov L; Banasik K; Rafnar T; Askling J; Klareskog L; Pedersen OB; Masson G; Havdahl A; Nilsson BA; Andreassen O; Daly M; Ostrowski SR; Jonsdottir I; Stefansson H; Holm H; Helgason A; Thorsteinsdottir U; Stefansson KF; Gudbjartsson D
• Article: JOURNAL OF RHEUMATOLOGY. 2023;50(6):781-788

  The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017

  Exarchou S; Wallman JK; Di Giuseppe D; Klingberg E; Sigurdardottir V; Wedren S; Lindstrom U; Turesson C; Jacobsson LTH; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(6):820-828

  Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

  Glintborg B; Di Giuseppe D; Wallman JK; Nordstrom DC; Gudbjornsson B; Hetland ML; Askling J; Grondal G; Sokka T; Provan SA; Michelsen B; Kristianslund EK; Dreyer L; Love TJ; Lindstrom U
• Letter: RHEUMATOLOGY. 2023;62(6):e204

  Comment on: The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis: reply

  Westerlind H; Kastbom A; Askling J
• Article: RHEUMATOLOGY. 2023;62(6):2106-2112

  The association between autoantibodies and risk for venous thromboembolic events among patients with rheumatoid arthritis

  Westerlind H; Kastbom A; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Skriner K; Bang H; Klareskog L; Saevarsdottir S; Lundberg K; Gronwall C; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(5):601-610

  Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

  Frisell T; Bower H; Morin M; Baecklund E; Di Giuseppe D; Delcoigne B; Feltelius N; Forsblad-d'Elia H; Lindqvist E; Lindstroem U; Askling J
• Article: AMERICAN HEART JOURNAL. 2023;259:42-51

  Associations between rheumatoid arthritis, incident heart failure, and left ventricular ejection fraction

  Faxen J; Benson L; Mantel A; Savarese G; Hage C; Dahlstrom U; Askling J; Lun LH; Andersson DC
• Article: ACR OPEN RHEUMATOLOGY. 2023;5(5):277-284

  Risk of Psychiatric Disorders in Juvenile Idiopathic Arthritis: Population- and Sibling-Controlled Cohort and Cross-Sectional Analyses

  Delcoigne B; Horne A; Askling J; Askling J
• Article: RMD OPEN. 2023;9(2):e002883

  Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study

  Lindstrom U; di Giuseppe D; Exarchou S; Alenius G-M; Olofsson T; Klingberg E; Jacobsson L; Askling J; Wallman JK
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(4):e88

  Response to: 'Correspondence on 'Risk of venous thromboembolism in rheumatoid arthritis and its association with disease activity: a nationwide cohort study from Sweden'' by Zervou et al

  Molander V; Askling J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2023;52(2):111-117

  Validation and characterization of venous thromboembolism diagnoses in the Swedish National Patient Register among patients with rheumatoid arthritis

  Molander V; Bower H; Askling J
• Article: RMD OPEN. 2023;9(1):e002924

  Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

  Delcoigne B; Kopp TI; Arkema EV; Hellgren K; Provan SA; Relas H; Aaltonen K; Trokovic N; Gudbjornsson B; Grondal G; Klami Kristianslund E; Lindhardsen J; Dreyer L; Askling J
• Article: RMD OPEN. 2023;9(1):e002753

  Occurrence and relative risks for non-vertebral fractures in patients with ankylosing spondylitis compared with the general population: a register-based study from Sweden

  Bengtsson K; Askling J; Lorentzon M; Rosengren B; Deminger A; Klingberg E; Jacobsson L; Forsblad-d'Elia H
• Article: RHEUMATOLOGY AND THERAPY. 2023;10(1):201-223

  Evaluation of VTE, MACE, and Serious Infections Among Patients with RA Treated with Baricitinib Compared to TNFi: A Multi-Database Study of Patients in Routine Care Using Disease Registries and Claims Databases

  Salinas CA; Louder A; Polinski J; Zhang TC; Bower H; Phillips S; Song Y; Rashidi E; Bosan R; Chang H-C; Foster N; Gershenson B; Yamanaka H; Kishimoto M; Tanaka Y; Fischer P; Zhu B; Faries D; Mai X; Doherty BT; Grelaud A; Thurin NH; Askling J; Deberdt W
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2023;82(2):189-197

  Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis

  Molander V; Bower H; Frisell T; Delcoigne B; Di Giuseppe D; Askling J
• Article: JOURNAL OF INTERNAL MEDICINE. 2023;293(2):246-258

  Post COVID-19 condition diagnosis: A population-based cohort study of occurrence, associated factors, and healthcare use by severity of acute infection

  Hedberg P; Granath F; Bruchfeld J; Askling J; Sjoholm D; Fored M; Farnert A; Naucler P
• Corrigendum: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2023;58:152141

  Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration (vol 56, 152081, 20222)

  Ornbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Pavelka K; Zavada J; Nissen MJ; Jones GT; Relas H; Pirila L; Tomsic M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; van der Horst-Bruinsma I; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Ostergaard M; Hetland ML
• Article: RHEUMATOLOGY. 2023;62(2):647-658

  Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

  Glintborg B; Di Giuseppe D; Wallman JK; Provan SA; Nordstrom D; Hokkanen A-M; Osterlund J; Kristianslund E; Kvien TK; Gudbjornsson B; Hetland ML; Michelsen B; Jacobsson L; Askling J; Lindstrom U
• Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2022;117(12):1971-1981

  Risk of Juvenile Idiopathic Arthritis and Rheumatoid Arthritis in Patients With Celiac Disease: A Population-Based Cohort Study

  Doyle JB; Lebwohl B; Askling J; Forss A; Green PHR; Roelstraete B; Soderling J; Ludvigsson JF
• Article: RMD OPEN. 2022;8(2):e002776

  Haematological malignancies in patients with psoriatic arthritis overall and treated with TNF inhibitors: a Nordic cohort study

  Cordtz RL; Askling J; Delcoigne B; Smedby KE; Baecklund E; Ballegaard C; Isomaki P; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Michelsen B; Sexton J; Dreyer L; Hellgren K
• Article: RMD OPEN. 2022;8(2):e002700

  Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study

  Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
• Corrigendum: RHEUMATOLOGY. 2022;61(12):4998

  Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration (vol 9, keac081, 2022)

  Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornsson B; Hetland ML; Michelsen B; Nordstrom D; Relas H; Askling J
• Article: RHEUMATOLOGY. 2022;61(12):4741-4751

  The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis

  Nissen M; Delcoigne B; Di Giuseppe D; Jacobsson L; Hetland ML; Ciurea A; Nekvindova L; Iannone F; Akkoc N; Sokka-Isler T; Fagerli KM; Santos MJ; Codreanu C; Pombo-Suarez M; Rotar Z; Gudbjornsson B; Van der Horst-Bruinsma I; Loft AG; Moeller B; Mann H; Conti F; Cetin GY; Relas H; Michelsen B; Ribeiro PA; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson AJ; Askling J; Glintborg B; Lindstroem U
• Article: RHEUMATOLOGY. 2022;61(11):4286-4296

  Do patient-reported measures of disease activity in rheumatoid arthritis vary between countries? Results from a Nordic collaboration

  Delcoigne B; Provan SA; Hammer HB; Di Giuseppe D; Frisell T; Glintborg B; Grondal G; Gudbjornson B; Hetland ML; Michelsen B; Nordstrom D; Relas H; Askling J
• Article: JOURNAL OF CROHN'S AND COLITIS. 2022;16(10):1540-1550

  Association Between Inflammatory Bowel Disease and Spondyloarthritis: Findings from a Nationwide Study in Sweden

  Shrestha S; Brand JS; Jaras J; Schoultz I; Montgomery S; Askling J; Ludvigsson JF; Olen O; Halfvarson J
• Article: RHEUMATOLOGY. 2022;61(10):3952-3962

  Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data

  Barbulescu A; Askling J; Chatzidionysiou K; Forsblad-d'Elia H; Kastbom A; Lindstrom U; Turesson C; Frisell T
• Editorial comment: ANIMAL CONSERVATION. 2022;25(5):612-613

  Towards an improved evidence-based Natura 2000 management strategy

  Kindvall O; Forsman A; Johansson V; Askling J; Franzen M
• Article: RMD OPEN. 2022;8(2):e002465

  Risk of lung cancer in rheumatoid arthritis and in relation to autoantibody positivity and smoking

  Chatzidionysiou K; di Giuseppe D; Soderling J; Catrina A; Askling J
• Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2022;75(4):480-484

  Colorectal Cancer in Childhood-onset Inflammatory Bowel Disease: A Scandinavian Register-based Cohort Study, 1969-2017

  Everhov AH; Ludvigsson JF; Jaras J; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Olen O
• Article: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2022;56:152081

  Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

  Ornbjerg LM; Linde L; Georgiadis S; Rasmussen SH; Lindstrom U; Askling J; Michelsen B; Di Giuseppe D; Wallman JK; Pavelka K; Zavada J; Nissen MJ; Jones GT; Relas H; Pirila L; Tomsic M; Rotar Z; Geirsson AJ; Gudbjornsson B; Kristianslund EK; Horst-Bruinsma IVS; Loft AG; Laas K; Iannone F; Corrado A; Ciurea A; Santos MJ; Santos H; Codreanu C; Akkoc N; Gunduz OS; Glintborg B; Ostergaard M; Hetland ML
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2022;56(7):1168-1182

  Colorectal cancer in elderly-onset inflammatory bowel disease: A 1969-2017 Scandinavian register-based cohort study

  Everhov AH; Erichsen R; Jaras J; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sorensen HT; Olen O
• Article: CLINICAL PHARMACOLOGY AND THERAPEUTICS. 2022;112(4):836-845

  Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data

  Barbulescu A; Askling J; Saevarsdottir S; Kim SC; Frisell T
• Article: RHEUMATOLOGY. 2022;61(9):3799-3807

  European bio-naive spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

  Christiansen SN; Ornbjerg LM; Rasmussen SH; Loft AG; Askling J; Iannone F; Zavada J; Michelsen B; Nissen M; Onen F; Santos MJ; Pombo-Suarez M; Relas H; Macfarlane GJ; Tomsic M; Codreanu C; Gudbjornsson B; Van der Horst-Bruinsma I; Di Giuseppe D; Glintborg B; Gremese E; Pavelka K; Kristianslund EK; Ciurea A; Akkoc N; Barcelos A; Sanchez-Piedra C; Peltomaa R; Jones GT; Rotar Z; Ionescu R; Grondal G; Van de Sande MGH; Laas K; Ostergaard M; Hetland ML
• Article: RHEUMATOLOGY. 2022;61(9):3647-3656

  The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries

  Di Giuseppe D; Lindstrom U; Aaltonen K; Relas H; Provan S; Gudbjornsson B; Hetland ML; Askling J; Kauppi M; Geirsson AJ; Chatzidionysiou K; Jorgensen TS; Dreyer L; Michelsen B; Jacobsson L; Glintborg B
• Article: RHEUMATOLOGY. 2022;61(9):3596-3605

  Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden

  Di Giuseppe D; Lindstrom U; Bower H; Delcoigne B; Frisell T; Chatzidionysiou K; Sjowall C; Lindqvist E; Askling J
• Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):203

  Neither low social support nor low decision latitude at work is associated with disease remission among patients with rheumatoid arthritis: results from the Swedish EIRA study

  Hedenstierna L; Hedstrom AK; Klareskog L; Di Giuseppe D; Alfredsson L; Askling J; Ernestam S; Saevarsdottir S; Ljung L
• Article: ARTHRITIS RESEARCH & THERAPY. 2022;24(1):185

  Does persistence to methotrexate treatment in early rheumatoid arthritis have a familial component?

  Sysojev AO; Frisell T; Delcoigne B; Saevarsdottir S; Askling J; Westerlind H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(8):1085-1095

  Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset

  Saevarsdottir S; Stefansdottir L; Sulem P; Thorleifsson G; Ferkingstad E; Rutsdottir G; Glintborg B; Westerlind H; Grondal G; Loft IC; Sorensen SB; Lie BA; Brink M; Arlestig L; Arnthorsson AO; Baecklund E; Banasik K; Bank S; Bjorkman LI; Ellingsen T; Erikstrup C; Frei O; Gjertsson I; Gudbjartsson DF; Gudjonsson SA; Halldorsson GH; Hendricks O; Hillert J; Hogdall E; Jacobsen S; Jensen DV; Jonsson H; Kastbom A; Kockum I; Kristensen S; Kristjansdottir H; Larsen MH; Linauskas A; Hauge E-M; Loft AG; Ludviksson BR; Lund SH; Markusson T; Masson G; Melsted P; Moore KHS; Munk H; Nielsen KR; Norddahl GL; Oddsson A; Olafsdottir TA; Olason PI; Olsson T; Ostrowski SR; Horslev-Petersen K; Rognvaldsson S; Sanner H; Silberberg GN; Stefansson H; Sorensen E; Sorensen IJ; Turesson C; Bergman T; Alfredsson L; Kvien TK; Brunak S; Steinsson K; Andersen V; Andreassen OA; Rantapaa-Dahlqvist S; Hetland ML; Klareskog L; Askling J; Padyukov L; Pedersen OB; Thorsteinsdottir U; Jonsdottir I; Stefansson K
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2022;56(3):491-500

  Age determines the risk of familial inflammatory bowel disease-A nationwide study

  Halfvarson JF; Ludvigsson JF; Bresso F; Askling J; Sachs MC; Olen O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(6):789-797

  Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries

  Delcoigne B; Ljung L; Provan SA; Glintborg B; Hetland ML; Gron KL; Peltomaa R; Relas H; Turesson C; Gudbjornsson B; Michelsen B; Askling J
• Article: RHEUMATOLOGY. 2022;61(5):1810-1818

  Short- and longer-term cancer risks with biologic and targeted synthetic disease-modifying antirheumatic drugs as used against rheumatoid arthritis in clinical practice

  Huss V; Bower H; Wadstrom H; Frisell T; Askling J
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(5):e74

  Response to: 'Neuroinflammatory events after anti-TNFα therapy' by Kaltsonoudis et al

  Kopp TI; Delcoigne B; Arkema EV; Magyari M; Locht H; Sellebjerg FT; Cordtz RL; Jensen DV; Askling J; Dreyer L
• Article: ARTHRITIS CARE AND RESEARCH. 2022;74(5):748-758

  One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses

  Glintborg B; Lindstrom U; Di Giuseppe D; Provan SA; Gudbjornsson B; Hetland ML; Michelsen B; Wallman JK; Aaltonen K; Hokkanen A-M; Nordstrom D; Jorgensen TS; Hansen RL; Geirsson AJ; Gron KL; Krogh NS; Askling J; Kristensen LE; Jacobsson LTH
• Article: RHEUMATOLOGY. 2022;61(3):1228-1232

  Juvenile idiopathic arthritis, marriage and parenthood: a nationwide matched cohort study

  Bruze G; Askling J; Horne A; Neovius M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2022;81(3):433-439

  Influenza outcomes in patients with inflammatory joint diseases and DMARDs: how do they compare to those of COVID-19?

  Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Askling J
• Article: HEART. 2022;108(6):467-473

  Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden

  Rossides M; Kullberg S; Grunewald J; Eklund A; Di Giuseppe D; Askling J; Arkema EV
• Article: RMD OPEN. 2022;8(1):e002018

  Allergic conditions and risk of rheumatoid arthritis: a Swedish case-control study

  Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Klareskog L; Holmqvist M; Askling J
• Letter: RHEUMATOLOGY. 2021;61(1):e31

  Comment on: Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA: results from a national register-based cohort study. Reply

  Bengtsson K; Forsblad-d'Elia H; Deminger A; Klingberg E; Dehlin M; Exarchou S; Lindstrom U; Askling J; Jacobsson LTH
• Article: RMD OPEN. 2021;7(3):e001987

  Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

  Bower H; Frisell T; di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1445-1452

  Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?

  Lindstrom U; Bengtsson K; Olofsson T; Di Giuseppe D; Glintborg B; Forsblad-d'Elia H; Jacobsson LTH; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(11):1410-1418

  Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

  Lindstrom U; Di Giuseppe D; Delcoigne B; Glintborg B; Moller B; Ciurea A; Pombo-Suarez M; Sanchez-Piedra C; Eklund K; Relas H; Gudbjornsson B; Love TJ; Jones GT; Codreanu C; Ionescu R; Nekvindova L; Zavada J; Atas N; Yolbas S; Fagerli KM; Michelsen B; Rotar Z; Tomsic M; Iannone F; Santos MJ; Avila-Ribeiro P; Ornbjerg LM; Ostergaard M; Jacobsson LTH; Askling J; Nissen MJ
• Article: RESPIRATORY MEDICINE. 2021;188:106624

  Risk of acute myocardial infarction in sarcoidosis: A population-based cohort study from Sweden

  Rossides M; Kullberg S; Grunewald J; Eklund A; Di Giuseppe D; Askling J; Arkema EV
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2021;56(10):1152-1162

  Adult-onset inflammatory bowel disease and rate of serious infections compared to the general population: a nationwide register-based cohort study 2002-2017

  Ludvigsson JF; Holmgren J; Grip O; Halfvarson J; Askling J; Sachs MC; Olen O
• Article: JOURNAL OF RHEUMATOLOGY. 2021;48(10):1512-1518

  Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis

  Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Peltomaa R; Aaltonen K; Trokovic N; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Grondal G; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson LTH; Askling J
• Article: RHEUMATOLOGY. 2021;60(8):3635-3645

  Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

  Lindstrom U; Glintborg B; Di Giuseppe D; Jorgensen TS; Gudbjornsson B; Gron KL; Provan SA; Michelsen B; Hetland ML; Wallman JK; Nordstrom D; Trokovic N; Love TJ; Krogh NS; Askling J; Jacobsson LTH; Kristensen LE
• Article: RHEUMATOLOGY. 2021;60(8):3760-3769

  Comorbidities at diagnosis of rheumatoid arthritis: a population-based case-control study

  Tidblad L; Westerlind H; Delcoigne B; Askling J; Saevarsdottir S
• Article: RHEUMATOLOGY. 2021;60(8):3656-3668

  Risk of solid cancers overall and by subtypes in patients with psoriatic arthritis treated with TNF inhibitors - a Nordic cohort study

  Hellgren K; Ballegaard C; Delcoigne B; Cordtz R; Nordstrom D; Aaltonen K; Gudbjornsson B; Love TJ; Provan SA; Sexton J; Zobbe K; Kristensen LE; Askling J; Dreyer L
• Article: JOURNAL OF RHEUMATOLOGY. 2021;48(8):1243-1250

  Tuberculosis in Biologic-naive Patients With Rheumatoid Arthritis: Risk Factors and Tuberculosis Characteristics

  Sundbaum JK; Arkema EV; Bruchfeld J; Jonsson J; Askling J; Baecklund E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(8):1086-1093

  Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

  Bower H; Frisell T; Di Giuseppe D; Delcoigne B; Ahlenius G-M; Baecklund E; Chatzidionysiou K; Feltelius N; Forsblad-d'Elia H; Kastbom A; Klareskog L; Lindqvist E; Lindstrom U; Turesson C; Sjowall C; Askling J
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2021;39(4):879-882

  Rheumatoid arthritis autoantibodies and their association with age and sex

  Pertsinidou E; Manivel VA; Westerlind H; Klareskog L; Alfredsson L; Mathsson-Alm L; Hansson M; Saevatsdottir S; Askling J; Ronnelid J
• Article: ACR OPEN RHEUMATOLOGY. 2021;3(7):457-463

  What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction?

  Westerlind H; Maciejewski M; Frisell T; Jelinsky SA; Ziemek D; Askling J
• Article: JOURNAL OF CROHN'S AND COLITIS. 2021;15(6):980-987

  Women's Earnings are more Affected by Inflammatory Bowel Disease than Men's: A Register-Based Swedish Cohort Study

  Everhov AH; Bruze G; Soderling J; Askling J; Halfvarson J; Westberg K; Malmborg P; Nordenvall C; Ludvigsson JF; Olen O
• Article: RHEUMATOLOGY. 2021;60(6):2725-2734

  Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study

  Bengtsson K; Forsblad-d'Elia H; Deminger A; Klingberg E; Dehlin M; Exarchou S; Lindstrom U; Askling J; Jacobsson LTH
• Article: RHEUMATOLOGY. 2021;60(5):2217-2222

  Mortality over 14 years in MTX-refractory patients randomized to a strategy of addition of infliximab or sulfasalazine and hydroxychloroquine

  Miller H; Wallman JK; Petersson IF; Saevarsdottir S; Soderlng J; Ernestam S; Askling J; van Vollenhoven R; Neovius M
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2021;50(3):178-182

  Social stressors and risk of rheumatoid arthritis and their relationship to known modifiable risk factors: results from the Swedish EIRA study

  Hedenstierna L; Opava CH; Askling J; Jiang X; Ernestam S; Alfredsson L; Klareskog L; Saevarsdottir S
• Article: RESPIROLOGY. 2021;26(5):452-460

  Infection risk in sarcoidosis patients treated with methotrexate compared to azathioprine: A retrospective 'target trial' emulated with Swedish real-world data

  Rossides M; Kullberg S; Di Giuseppe D; Eklund A; Grunewald J; Askling J; Arkema EV
• Letter: GUT. 2021;70(5):998

  Reply: Survival in Crohn's disease-associated small bowel adenocarcinoma

  Axelrad JE; Olen O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Ludvigsson JF
• Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2021;30(5):886-894

  Hepatobiliary Cancer Risk in Patients with Inflammatory Bowel Disease: A Scandinavian Population-Based Cohort Study

  Erichsen R; Olen O; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sorensen HT
• Article: ARTHRITIS CARE AND RESEARCH. 2021;73(5):658-665

  Findings on Coronary Angiographies in Patients With Rheumatoid Arthritis and Ischemic Heart Disease: Are They Different From Patients Without Rheumatoid Arthritis?

  Holmqvist M; Mantel A; Wallberg-Jonsson S; James S; Jernberg T; Askling J
• Article: CLINICAL RHEUMATOLOGY. 2021;40(4):1321-1329

  Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing spondylitis

  Sodergren A; Askling J; Bengtsson K; Forsblad-d'Elia H; Jernberg T; Lindstrom U; Ljung L; Mantel A; Jacobsson LTH
• Article: LIVER INTERNATIONAL. 2021;41(3):545-553

  Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers

  Hagstrom H; Ndegwa N; Jalmeus M; Ekstedt M; Posserud I; Rorsman F; Nyhlin N; Klintman D; Werner M; Marschall H-U; Askling J; Stal P
• Article: GUT. 2021;70(2):297-308

  Inflammatory bowel disease and risk of small bowel cancer: a binational population-based cohort study from Denmark and Sweden

  Axelrad JE; Olen O; Sachs MC; Erichsen R; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Ludvigsson JF
• Article: RHEUMATOLOGY. 2021;60(2):820-828

  The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

  Courvoisier DS; Chatzidionysiou K; Mongin D; Lauper K; Mariette X; Morel J; Gottenberg J-E; Bergstra SA; Suarez MP; Codreanu C; Kvien TK; Santos MJ; Pavelka K; Hetland ML; Askling J; Turesson C; Kubo S; Tanaka Y; Iannone F; Choquette D; Nordstrom DC; Rotar Z; Lukina G; Gabay C; Van Vollenhoven R; Finckh A
• Article: RHEUMATOLOGY. 2021;60(2):809-819

  Lymphoma risks in patients with rheumatoid arthritis treated with biological drugs-a Swedish cohort study of risks by time, drug and lymphoma subtype

  Hellgren K; Di Giuseppe D; Smedby KE; Sundstrom C; Askling J; Baecklund E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2021;80(2):169-175

  Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden

  Molander V; Bower H; Frisell T; Askling J
• Article: RHEUMATOLOGY. 2021;60(1):140-146

  Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study

  Hansen RL; Jorgensen TS; Dreyer L; Hetland ML; Glintborg B; Askling J; Di Giuseppe D; Jacobsson LTH; Wallman JK; Nordstrom D; Aaltonen K; Kristianslund EK; Kvien TK; Provan SA; Gudbjornsson B; Love TJ; Kristensen LE
• Article: CLINICAL EPIDEMIOLOGY. 2021;13:21-41

  Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden

  Ludvigsson JF; Appelros P; Askling J; Byberg L; Carrero J-J; Ekstrom AM; Ekstrom M; Smedby KE; Hagstrom H; James S; Jarvholm B; Michaelsson K; Pedersen NL; Sundelin H; Sundquist K; Sundstrom J
• Article: ARTHRITIS & RHEUMATOLOGY. 2021;73(1):61-68

  Respiratory Diseases as Risk Factors for Seropositive and Seronegative Rheumatoid Arthritis and in Relation to Smoking

  Kronzer VL; Westerlind H; Alfredsson L; Crowson CS; Nyberg F; Tornling G; Klareskog L; Holmqvist M; Askling J
• Article: EUROPEAN JOURNAL OF HAEMATOLOGY. 2020;105(6):779-785

  Concordance in survival among first-degree relatives diagnosed with indolent lymphoid malignancies including chronic lymphocytic leukemia

  Baecklund F; Ekberg S; Rosenquist R; Askling J; Eloranta S; Smedby KE
• Article: RMD OPEN. 2020;6(3):e001463

  Is rheumatoid arthritis a risk factor for acute coronary syndrome also among individuals at elevated risk, such as individuals presenting with acute chest pain?

  Svensson P; Bergstrom M; Discacciati A; Ljung L; Jernberg T; Frick M; Linder R; Askling J
• Article: EUROPEAN JOURNAL OF EPIDEMIOLOGY (EJE). 2020;35(11):1087-1097

  Are infectious diseases risk factors for sarcoidosis or a result of reverse causation? Findings from a population-based nested case-control study

  Rossides M; Kullberg S; Askling J; Eklund A; Grunewald J; Di Giuseppe D; Arkema EV
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2020;55(10):1205-1210

  Validity of administrative codes associated with cirrhosis in Sweden

  Bengtsson B; Askling J; Ludvigsson JF; Hagstrom H
• Article: ARTHRITIS & RHEUMATOLOGY. 2020;72(10):1658-1667

  Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis

  Westerlind H; Ronnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson P-J; Skriner K; Klareskog L; Saevarsdottir S; Askling J
• Article: RMD OPEN. 2020;6(3):e001280

  Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration.

  Michelsen B; Lindström U; Codreanu C; Ciurea A; Zavada J; Loft AG; Pombo-Suarez M; Onen F; Kvien TK; Rotar Z; Santos MJ; Iannone F; Hokkanen A-M; Gudbjornsson B; Askling J; Ionescu R; Nissen MJ; Pavelka K; Sanchez-Piedra C; Akar S; Sexton J; Tomsic M; Santos H; Sebastiani M; Österlund J; Geirsson AJ; Macfarlane G; van der Horst-Bruinsma I; Georgiadis S; Brahe CH; Ørnbjerg LM; Hetland ML; Østergaard M
• Article: EUROPEAN RESPIRATORY JOURNAL. 2020;56(3):2000767

  Risk of first and recurrent serious infection in sarcoidosis: a Swedish register-based cohort study

  Rossides M; Kullberg S; Eklund A; Di Giuseppe D; Grunewald J; Askling J; Arkema EV
• Article: RMD OPEN. 2020;6(2):e001363

  How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers

  Chatzidionysiou K; Delcoigne B; Frisell T; Hetland ML; Glintborg B; Dreyer L; Cordtz R; Zobbe K; Nordstrom D; Trokovic N; Aaltonen K; Provan SA; Grondal G; Gudbjornsson B; Askling J
• Article: RHEUMATOLOGY. 2020;59(9):2455-2461

  Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis

  Michelsen B; Ornbjerg LM; Kvien TK; Pavelka K; Nissen MJ; Nordstrom D; Santos MJ; Koca SS; Askling J; Rotar Z; Gudbjornsson B; Codreanu C; Loft AG; Kristianslund EK; Mann HF; Ciurea A; Eklund KK; Vieira-Sousa E; Yazici A; Jacobsson L; Tomsic M; Love TJ; Ionescu R; van der Horst-Bruinsma IE; Iannone F; Pombo-Suarez M; Jones GT; Hyldstrup LH; Krogh NS; Hetland ML; Ostergaard M
• Article: NATURE. 2020;584(7822):619-623

  FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease

  Saevarsdottir S; Olafsdottir TA; Ivarsdottir EV; Halldorsson GH; Gunnarsdottir K; Sigurdsson A; Johannesson A; Sigurdsson JK; Juliusdottir T; Lund SH; Arnthorsson AO; Styrmisdottir EL; Gudmundsson J; Grondal GM; Steinsson K; Alfredsson L; Askling J; Benediktsson R; Bjarnason R; Geirsson AJ; Gudbjornsson B; Gudjonsson H; Hjaltason H; Hreidarsson AB; Klareskog L; Kockum I; Kristjansdottir H; Love TJ; Ludviksson BR; Olsson T; Onundarson PT; Orvar KB; Padyukov L; Sigurgeirsson B; Tragante V; Bjarnadottir K; Rafnar T; Masson G; Sulem P; Gudbjartsson DF; Melsted P; Thorleifsson G; Norddahl GL; Thorsteinsdottir U; Jonsdottir I; Stefansson K
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2020;52(4):655-668

  Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden

  Khalili H; Everhov AH; Halfvarson J; Ludvigsson JF; Askling J; Myrelid P; Soderling J; Olen O; Neovius M
• Article: RMD OPEN. 2020;6(2):e001282

  Does autoimmune thyroid disease affects rheumatoid arthritis disease activity or response to methotrexate?

  Waldenlind K; Delcoigne B; Saevarsdottir S; Askling J
• Article: RMD OPEN. 2020;6(2):e001201

  Gastrointestinal perforations in patients with rheumatoid arthritis treated with biological disease-modifying antirheumatic drugs in Sweden: a nationwide cohort study

  Barbulescu A; Delcoigne B; Askling J; Frisell T
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2020;52(1):143-154

  Inflammatory bowel disease and pancreatic cancer: a Scandinavian register-based cohort study 1969-2017

  Everhov AH; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Ludvigsson JF; Sorensen HT; Olen O
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(6):685-699

  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

  Smolen JS; Landewe RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M; Aletaha D; Aringer M; Askling J; Balsa A; Boers M; den Broeder AA; Buch MH; Buttgereit F; Caporali R; Cardiel MH; De Cock D; Codreanu C; Cutolo M; Edwards CJ; van Eijk-Hustings Y; Emery P; Finckh A; Gossec L; Gottenberg J-E; Hetland ML; Huizinga TWJ; Koloumas M; Li Z; Mariette X; Mueller-Ladner U; Mysler EF; da Silva JAP; Poor G; Pope JE; Rubbert-Roth A; Ruyssen-Witrand A; Saag KG; Strangfeld A; Takeuchi T; Voshaar M; Westhovens R; van der Heijde D
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2020;49(3):225-232

  Population-based study of patients with primary Sjogren's syndrome and lymphoma: lymphoma subtypes, clinical characteristics, and gender differences

  Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Ronnblom L; Sundstrom C; Baecklund E
• Article: RMD OPEN. 2020;6(1):e001197

  Siblings of patients with rheumatoid arthritis have an increased mortality rate: a Swedish cohort study

  Westerlind H; Delcoigne B; Askling J
• Article: ANNALS OF NEUROLOGY. 2020;87(5):688-699

  Cancer Risk for Fingolimod, Natalizumab, and Rituximab in Multiple Sclerosis Patients

  Alping P; Askling J; Burman J; Fink K; Fogdell-Hahn A; Gunnarsson M; Hillert J; Langer-Gould A; Lycke J; Nilsson P; Salzer J; Svenningsson A; Vrethem M; Olsson T; Piehl F; Frisell T
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):566-572

  Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden

  Kopp TI; Delcoigne B; Arkema EV; Jacobsen RK; Magyari M; Ibfelt EH; Locht H; Sellebjerg F; Cordtz RL; Jensen DV; Askling J; Dreyer L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):581-586

  Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors

  Wadstrom H; Pettersson A; Smedby KE; Askling J
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2020;79(5):e50

  Response to: 'Inflammatory and non-inflammatory triggers of acute coronary syndromes' by Eyuboglu

  Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
• Article: THE LANCET GASTROENTEROLOGY AND HEPATOLOGY. 2020;5(5):475-484

  Colorectal cancer in Crohn's disease: a Scandinavian population-based cohort study

  Olen O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Ludvigsson JF
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2020;51(8):789-800

  Adult height in patients with childhood-onset inflammatory bowel disease: a nationwide population-based cohort study

  Mouratidou N; Malmborg P; Sachs MC; Askling J; Ekbom A; Neovius M; Smedby KE; Savendahl L; Ludvigsson JF; Olen O
• Article: GUT. 2020;69(3):453-461

  Mortality in adult-onset and elderly-onset IBD: a nationwide register-based cohort study 1964-2014

  Olen O; Askling J; Sachs MC; Neovius M; Smedby KE; Ekbom A; Ludvigsson JF
• Article: THE LANCET. 2020;395(10218):123-131

  Colorectal cancer in ulcerative colitis: a Scandinavian population-based cohort study

  Olen O; Erichsen R; Sachs MC; Pedersen L; Halfvarson J; Askling J; Ekbom A; Sorensen HT; Ludvigsson JF
• Article: CLINICAL EPIDEMIOLOGY. 2020;12:273-285

  Work Loss in Relation to Pharmacological and Surgical Treatment for Crohn's Disease: A Population-Based Cohort Study

  Everhov A; Sachs M; Ludvigsson J; Khalili H; Askling J; Neovius M; Myrelid P; Halfvarson J; Nordenvall C; Soderling J; Olen O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(11):1536-1544

  Treatment response and drug retention rates in 24 195 biologic-naive patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

  Ornbjerg LM; Brahe CH; Askling J; Ciurea A; Mann H; Onen F; Kristianslund EK; Nordstrom D; Santos MJ; Codreanu C; Gomez-Reino J; Rotar Z; Gudbjornsson B; Di Giuseppe D; Nissen MJ; Pavelka K; Birlik M; Kvien T; Eklund KK; Barcelos A; Ionescu R; Sanchez-Piedra C; Tomsic M; Geirsson AJ; Loft AG; van der Horst-Bruinsma I; Jones G; Iannone F; Hyldstrup L; Krogh NS; Hetland ML; Ostergaard M
• Letter: RESPIRATORY MEDICINE. 2019;160:105696

  Correspondence for "Clinical epidemiology of familial sarcoidosis: A systematic literature review"

  Rossides M; Grunewald J; Eklund A; Kullberg S; Askling J; Arkema EV
• Article: INFLAMMATORY BOWEL DISEASES. 2019;25(10):1663-1673

  Effects of Childhood-onset Inflammatory Bowel Disease on School Performance: A Nationwide Population-based Cohort Study Using Swedish Health and Educational Registers

  Malmborg P; Mouratidou N; Sachs MC; Hammar U; Khalili H; Neovius M; Hjern A; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Olen O
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(9):1160-1166

  2018 EULAR recommendations for a core data set to support observational research and clinical care in giant cell arteritis

  Ehlers L; Askling J; Bijlsma HWJ; Cid MC; Cutolo M; Dasgupta B; Dejaco C; Dixon WG; Feltelius N; Finckh A; Gilbert K; Mackie SL; Mahr A; Matteson EL; Neill L; Salvarani C; Schmidt WA; Strangfeld A; van Vollenhoven RF; Buttgereit F
• Letter: RHEUMATOLOGY. 2019;58(8):1510-1511

  Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply

  Frisell T; Askling J
• Letter: RHEUMATOLOGY. 2019;58(8):1507-1509

  Comment on: Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register: reply

  Frisell T; Askling J
• Article: INFLAMMATORY BOWEL DISEASES. 2019;25(7):1237-1247

  Work Loss Before and After Diagnosis of Crohn's Disease

  Everhov AH; Khalili H; Askling J; Myrelid P; Ludvigsson JF; Halfvarson J; Nordenvall C; Neovius M; Soderling J; Olen O
• Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2019;17(7):1311-1322.e7

  Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study

  Axelrad JE; Olen O; Askling J; Lebwohl B; Khalili H; Sachs MC; Ludvigsson JF
• Article: ARTHRITIS RESEARCH & THERAPY. 2019;21(1):128

  Biological treatment of ankylosing spondylitis: a nationwide study of treatment trajectories on a patient level in clinical practice

  Lindstrom U; Olofsson T; Wedren S; Qirjazo I; Askling J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2019;48(3):207-212

  Comparison of patients with and without pre-existing lymphoma at diagnosis of primary Sjogren's syndrome

  Vasaitis L; Nordmark G; Theander E; Backlin C; Smedby KE; Askling J; Ronnblom L; Sundstrom C; Baecklund E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(5):683-687

  Siblings of patients with rheumatoid arthritis are at increased risk of acute coronary syndrome

  Westerlind H; Holmqvist M; Ljung L; Frisell T; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2019;78(3):320-327

  Risk of serious infections in patients with rheumatoid arthritis treated in routine care with abatacept, rituximab and tocilizumab in Denmark and Sweden

  Gron KL; Arkema EV; Glintborg B; Mehnert F; Ostergaard M; Dreyer L; Norgaard M; Krogh NS; Askling J; Hetland ML; Askling J; Klareskog L; Feltelius N; Baecklund E; Sjowall C; Rantapaa-Dahlqvist S; Forsblad-d'Elia H; Jacobsson L; Turesson C; Lindqvist E; Nisell R
• Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2019;114(2):291-304

  Fracture Risk in Patients With Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study From 1964 to 2014

  Ludvigsson JF; Mahl M; Sachs MC; Bjork J; Michaelsson K; Ekbom A; Askling J; Backman A-S; Olen O
• Article: GASTROENTEROLOGY. 2019;156(3):614-622

  Increased Mortality of Patients With Childhood- Onset Inflammatory Bowel Diseases, Compared With the General Population

  Olen O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
• Article: RHEUMATOLOGY. 2019;58(8):1367-1377

  Comparative effectiveness of abatacept, rituximab, tocilizumab and TNFi biologics in RA: results from the nationwide Swedish register

  Frisell T; Dehlin M; Di Giuseppe D; Feltelius N; Turesson C; Askling J; Ernestam S; Klareskog L; Nisell R; Baecklund E; Kastbom A; Jacobsson L; Lindqvist E; d'Elia HF; Rantapaa-Dahlqvist S
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2019;54(1):55-63

  Changes in inflammatory bowel disease subtype during follow-up and over time in 44,302 patients

  Everhov AH; Sachs MC; Malmborg P; Nordenvall C; Myrelid P; Khalili H; Elmberg M; Ekbom A; Askling J; Jakobsson G; Halfvarson J; Ludvigsson JF; Olen O
• Article: RMD OPEN. 2019;5(2):e000978

  Occupational exposure to asbestos and silica and risk of developing rheumatoid arthritis: findings from a Swedish population-based case-control study

  Ilar A; Klareskog L; Saevarsdottir S; Wiebert P; Askling J; Gustaysson P; Alfredsson L
• Article: RMD OPEN. 2019;5(2):e001055

  Juvenile idiopathic arthritis and risk of cancer before and after the introduction of biological therapies

  Horne A; Delcoigne B; Palmblad K; Askling J
• Article: RMD OPEN. 2019;5(2):e001079

  Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naive patients with spondyloarthritis

  Lindstrom U; Glintborg B; Di Giuseppe D; Nordstrom D; Provan SA; Gudbjornsson B; Askling J; Hetland ML; Aaltonen K; Krogh NS; Geirsson AJ; Jacobsson LTH
• Article: LIVER INTERNATIONAL. 2019;39(1):197-204

  Cardiovascular risk factors in non-alcoholic fatty liver disease

  Hagstrom H; Nasr P; Ekstedt M; Hammar U; Stal P; Askling J; Hultcrantz R; Kechagias S
• Article: JOURNAL OF CROHN'S AND COLITIS. 2018;12(12):1418-1428

  Sick Leave and Disability Pension in Prevalent Patients With Crohn's Disease

  Everhov AH; Khalili H; Askling J; Myrelid P; Ludvigsson JF; Halfvarson J; Nordenvall C; Soderling J; Olen O; Neovius M
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(6):465-474

  Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries

  Glintborg B; Lindstrom U; Aaltonen K; Kristianslund EK; Gudbjornsson B; Chatzidionysiou K; Askling J; Nordstrom D; Hetland ML; Di Giuseppe D; Dreyer L; Kristensen LE; Jorgensen TS; Eklund K; Grondal G; Ernestam S; Joensuu J; Tormanen MRK; Skydsgaard H; Hagfors J; Kvien TK; Lie E; Fagerli K; Geirsson AJ; Jonsson H; Provan SA; Krogh NS; Jacobsson LTH
• Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2018;113(11):1711-1719

  Pancreatic Cancer Following Acute Pancreatitis: A Population-based Matched Cohort Study

  Sadr-Azodi O; Oskarsson V; Discacciati A; Askling J; Videhult P; Ekbom A
• Article: JAMA NETWORK OPEN. 2018;1(6):e183567

  Risk of Thyroxine-Treated Autoimmune Thyroid Disease Associated With Disease Onset in Patients With Rheumatoid Arthritis

  Waldenlind K; Saevarsdottir S; Bengtsson C; Askling J
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(10):1536-1537

  Transmission of rheumatoid arthritis through blood transfusion: a retrospective cohort study

  Just SA; Rostgaard K; Titlestad K; Edgren G; Erikstrup C; Ullum H; Pedersen OB; Nielsen KR; Askling J; Lindegaard H; Hjalgrim H
• Article: ARTHRITIS CARE AND RESEARCH. 2018;70(10):1563-1567

  Tuberculosis Risk in Ankylosing Spondylitis, Other Spondyloarthritis, and Psoriatic Arthritis in Sweden: A Population-Based Cohort Study

  de Vries MK; Arkema EV; Jonsson J; Bruchfeld J; Jacobsson LTH; Askling J
• Article: ANNALS OF INTERNAL MEDICINE. 2018;169(5):291-299

  Tumor Necrosis Factor Inhibitors and Cancer Recurrence in Swedish Patients With Rheumatoid Arthritis A Nationwide Population-Based Cohort Study

  Raaschou P; Soderling J; Turesson C; Askling J
• Article: ARTHRITIS RESEARCH & THERAPY. 2018;20(1):175

  Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study

  Johansson K; Askling J; Alfredsson L; Di Giuseppe D
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(8):1236-1238

  Seropositivity combined with smoking is associated with increased prevalence of periodontitis in patients with rheumatoid arthritis

  Eriksson K; Nise L; Alfredsson L; Catrina AI; Askling J; Lundberg K; Klareskog L; Yucel-Lindberg T
• Article: EUROPEAN RESPIRATORY JOURNAL. 2018;52(2):1800385

  Familial aggregation and heritability of sarcoidosis: a Swedish nested case-control study

  Rossides M; Grunewald J; Eklund A; Kullberg S; Di Giuseppe D; Askling J; Arkema EV
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2018;47(4):270-275

  Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis

  Baecklund E; Backlin C; Ronnelid J; Toes R; Huizinga TWJ; Ahlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
• Article: EXPERT OPINION ON BIOLOGICAL THERAPY. 2018;18(5):499-504

  Uptake of rheumatology biosimilars in the absence of forced switching

  Di Giuseppe D; Frisell T; Ernestam S; Forsblad-D'Elia H; Lindqvist E; Lindstrom U; Sjowall C; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(5):650-657

  Patient characteristics influence the choice of biological drug in RA, and will make non-TNFi biologics appear more harmful than TNFi biologics

  Frisell T; Baecklund E; Bengtsson K; Di Giuseppe D; Forsblad-d'Elia H; Askling J
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(4):476-479

  2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

  Radner H; Chatzidionysiou K; Nikiphorou E; Gossec L; Hyrich KL; Zabalan C; van Eijk-Hustings Y; Williamson PR; Balanescu A; Burmester GR; Carmona L; Dougados M; Finckh A; Haugeberg G; Hetland ML; Oliver S; Porter D; Raza K; Ryan P; Santos MJ; van der Helm-van Mil A; van Riel P; von Krause G; Zavada J; Dixon WG; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(4):541-548

  Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden

  Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindstrom U; Askling J; Jacobsson LTH
• Article: GASTROENTEROLOGY. 2018;154(3):518-528.e15

  Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden

  Everhov AH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Soderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olen O
• Article: EUROPEAN RESPIRATORY JOURNAL. 2018;51(2):1701815

  Sarcoidosis mortality in Sweden: a population-based cohort study

  Rossides M; Kullberg S; Askling J; Eklund A; Grunewald J; Arkema EV
• Article: JOURNAL OF CROHN'S AND COLITIS. 2018;12(2):157-166

  Surgical Treatment in Childhood-onset Inflammatory Bowel Disease-A Nationwide Register-based Study of 4695 Incident Patients in Sweden 2002-2014

  Nordenvall C; Rosvall O; Bottai M; Everhov AH; Malmborg P; Smedby KE; Ekbom A; Askling J; Ludvigsson JF; Myrelid P; Olen O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2018;77(1):85-91

  Mortality following new-onset Rheumatoid Arthritis: has modern Rheumatology had an impact?

  Holmqvist M; Ljung L; Askling J
• Review: RMD OPEN. 2018;4(1):e000655

  Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

  Chatzidionysiou K; Hetland ML; Frisell T; Di Giuseppe D; Hellgren K; Glintborg B; Nordstrom D; Aaltonen K; Tormanen MRK; Kristianslund EK; Kvien TK; Provan SA; Guobjornsson B; Dreyer L; Kristensen LE; Jorgensen TS; Jacobsson L; Askling J
• Article: RMD OPEN. 2018;4(2):e000762

  Impact of extra-articular spondyloarthritis manifestations and comorbidities on drug retention of a first TNF-inhibitor in ankylosing spondylitis: a population-based nationwide study

  Lindstrom U; Olofsson T; Wedren S; Qirjazo I; Askling J
• Article: RMD OPEN. 2018;4(2):e000771

  Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation

  Ljung L; Ueda P; Liao KP; Greenberg JD; Etzel CJ; Solomon DH; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(12):2017-2024

  Long-term outcomes and secondary prevention after acute coronary events in patients with rheumatoid arthritis

  Mantel A; Holmqvist M; Jernberg T; Wallberg-Jonsson S; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(12):2025-2030

  Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project

  Mercer LK; Regierer AC; Mariette X; Dixon WG; Baecklund E; Hellgren K; Dreyer L; Hetland ML; Cordtz R; Hyrich K; Strangfeld A; Zink A; Canhao H; Victoria Hernandez M; Tubach F; Gottenberg J-E; Morel J; Zavada J; Iannone F; Askling J; Listing J
• Article: JAMA INTERNAL MEDICINE. 2017;177(11):1605-1612

  Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice A Nationwide Cohort Study From Sweden

  Wadstroem H; Frisell T; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(11):1809-1814

  Juvenile onset arthritis and pregnancy outcome: a population-based cohort study

  Remaeus K; Johansson K; Askling J; Stephansson O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(10):1642-1647

  Acute coronary syndrome in new-onset rheumatoid arthritis: a population-based nationwide cohort study of time trends in risks and excess risks

  Holmqvist M; Ljung L; Askling J
• Article: THE BMJ. 2017;358:j3951

  Childhood onset inflammatory bowel disease and risk of cancer: a Swedish nationwide cohort study 1964-2014

  Olen O; Askling J; Sachs MC; Frumento P; Neovius M; Smedby KE; Ekbom A; Malmborg P; Ludvigsson JF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(9):1515-1521

  Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register

  Lie E; Lindstrom U; Zverkova-Sandstrom T; Olsen IC; Forsblad-d'Elia H; Askling J; Kapetanovic MC; Kristensen LE; Jacobsson LTH
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2017;46(6):589-598

  Anti-TNF treatment in Crohn's disease and risk of bowel resection-a population based cohort study

  Eberhardson M; Soderling JK; Neovius M; Cars T; Myrelid P; Ludvigsson JF; Askling J; Ekbom A; Olen O
• Editorial comment: ARTHRITIS & RHEUMATOLOGY. 2017;69(8):1509-1511

  Is Rheumatoid Arthritis a Mortal Disease?

  Askling J; Holmqvist M; Ljung L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(7):1245-1252

  Predictors of work disability after start of anti-TNF therapy in a national cohort of Swedish patients with rheumatoid arthritis: does early anti-TNF therapy bring patients back to work?

  Olofsson T; Petersson IF; Eriksson JK; Englund M; Nilsson JA; Geborek P; Jacobsson LTH; Askling J; Neovius M
• Article: ARTHRITIS RESEARCH & THERAPY. 2017;19(1):102

  Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study

  Bengtsson K; Forsblad-d'Elia H; Lie E; Klingberg E; Dehlin M; Exarchou S; Lindstrom U; Askling J; Jacobsson LTH
• Article: AMERICAN JOURNAL OF EPIDEMIOLOGY. 2017;185(8):681-687

  Possible Interaction Between Cigarette Smoking and HLA-DRB1 Variation in the Risk of Follicular Lymphoma

  Baecklund F; Foo J-N; Askling J; Eloranta S; Glimelius I; Liu J; Hjalgrim H; Rosenquist R; Padyukov L; Smedby KE
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(4):700-708

  Rheumatoid Arthritis and Risk of Malignant Lymphoma

  Hellgren K; Baecklund E; Backlin C; Sundstrom C; Smedby KE; Askling J
• Article: RHEUMATOLOGY. 2017;56(4):613-619

  Cervical neoplasia in systemic lupus erythematosus: a nationwide study

  Wadstrom H; Arkema EV; Sjowall C; Askling J; Simard JF
• Article: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2017;69(10):1275-1285

  Association Between Rheumatoid Arthritis and Risk of Ischemic and Nonischemic Heart Failure

  Mantel A; Holmqvist M; Andersson DC; Lund LH; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(2):364-370

  Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?

  Eriksson JK; Jacobsson L; Bengtsson K; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(2):386-391

  Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

  Mercer LK; Askling J; Raaschou P; Dixon WG; Dreyer L; Hetland ML; Strangfeld A; Zink A; Mariette X; Finckh A; Canhao H; Lannone F; Zavada J; Morel J; Gottenberg J-E; Hyrich KL; Listing J
• Article: BMC GASTROENTEROLOGY. 2017;17(1):23

  Prevalence of paediatric inflammatory bowel disease in Sweden: a nationwide population-based register study

  Ludvigsson JF; Busch K; Olen O; Askling J; Smedby KE; Ekbom A; Lindberg E; Neovius M
• Article: RMD OPEN. 2017;3(2):e000498

  Infection rates in patients from five rheumatoid arthritis (RA) registries: contextualising an RA clinical trial programme.

  Yamanaka H; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Novelli Horne L; Inoue E; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Nyberg F
• Article: ARTHRITIS & RHEUMATOLOGY. 2017;69(1):143-147

  Sex Ratio of Offspring Born to Women With Systemic Lupus Erythematosus or Rheumatoid Arthritis

  Arkema EV; Askling J; Salmon JE; Simard JF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):105-111

  Cancer risk in patients with spondyloarthritis treated with TNF inhibitors: a collaborative study from the ARTIS and DANBIO registers

  Hellgren K; Dreyer L; Arkema EV; Glintborg B; Jacobsson LTH; Kristensen L-E; Feltelius N; Hetland ML; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2017;76(1):119-125

  How well do ACPA discriminate and predict RA in the general population: a study based on 12 590 population-representative Swedish twins

  Hensvold AH; Frisell T; Magnusson PKE; Holmdahl R; Askling J; Catrina AI
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):288

  A genetic risk score composed of rheumatoid arthritis risk alleles, HLA-DRB1 haplotypes, and response to TNFi therapy - results from a Swedish cohort study

  Jiang X; Askling J; Saevarsdottir S; Padyukov L; Alfredsson L; Viatte S; Frisell T
• Article: EUROPEAN RESPIRATORY JOURNAL. 2016;48(6):1690-1699

  Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden

  Arkema EV; Grunewald J; Kullberg S; Eklund A; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(12):2087-2094

  Response to biological treatment and subsequent risk of coronary events in rheumatoid arthritis

  Ljung L; Rantapaeae-Dahlqvist S; Jacobsson LTH; Askling J
• Article: AMERICAN JOURNAL OF GASTROENTEROLOGY. 2016;111(11):1614-1620

  Oral Contraceptive Use and Risk of Ulcerative Colitis Progression: A Nationwide Study

  Khalili H; Neovius M; Ekbom A; Ludvigsson JF; Askling J; Chan AT; Olen O
• Review: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):251

  Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

  Nikiphorou E; Radner H; Chatzidionysiou K; Desthieux C; Zabalan C; van Eijk-Hustings Y; Dixon WG; Hyrich KL; Askling J; Gossec L
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18(1):240

  Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study

  Lindstrom U; Exarchou S; Lie E; Dehlin M; Forsblad-d'Elia H; Askling J; Jacobsson L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1797-1805

  Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease

  Michaud K; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Nyberg F; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Yamanaka H; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1838-1842

  Pregnancy outcomes in patients with ankylosing spondylitis: a nationwide register study

  Jakobsson GL; Stephansson O; Askling J; Jacobsson LTH
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(10):1789-1796

  How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries

  Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Ho M; Holmqvist M; Horne L; Inoue E; Michaud K; Nyberg F; Pappas DA; Reed G; Tanaka E; Tran TN; Verstappen SMM; Yamanaka H; Wesby-van Swaay E; Symmons D
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(8):1466-1472

  Mortality in ankylosing spondylitis: results from a nationwide population-based study

  Exarchou S; Lie E; Lindstrom U; Askling J; Forsblad-d'Elia H; Turesson C; Kristensen LE; Jacobsson LTH
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(7):1272-1278

  Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden

  Wadstrom H; Frisell T; Sparen P; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(6):1120-1125

  Does a family history of RA influence the clinical presentation and treatment response in RA?

  Frisell T; Saevarsdottir S; Askling J
• Review: NATURE REVIEWS. RHEUMATOLOGY. 2016;12(6):335-343

  Family history of rheumatoid arthritis: an old concept with new developments

  Frisell T; Saevarsdottir S; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(5):862-866

  What is the impact of chronic systemic inflammation such as rheumatoid arthritis on mortality following cancer?

  Simard JF; Ekberg S; Johansson ALV; Askling J
• Article: RHEUMATOLOGY. 2016;55(4):729-734

  Does disease activity at start of biologic therapy influence work-loss in RA patients?

  Olofsson T; Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Petersson IF; Askling J; Neovius M
• Article: THE BMJ. 2016;352:i262

  Rheumatoid arthritis, anti-tumour necrosis factor treatment, and risk of squamous cell and basal cell skin cancer: cohort study based on nationwide prospectively recorded data from Sweden

  Raaschou P; Simard JF; Hagelberg CA; Askling J
• Article: ARTHRITIS RESEARCH & THERAPY. 2016;18:16

  Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers

  Lindstrom U; Forsblad-d'Elia H; Askling J; Kristensen LE; Lie E; Exarchou S; Jacobsson L
• Article: MULTIPLE SCLEROSIS JOURNAL. 2016;22(1):85-93

  Comparative analysis of first-year fingolimod and natalizumab drug discontinuation among Swedish patients with multiple sclerosis

  Frisell T; Forsberg L; Nordin N; Kiesel C; Alfredsson L; Askling J; Hillert J; Olsson T; Piehl F
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2016;75(1):183-189

  Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden

  Frisell T; Hellgren K; Alfredsson L; Raychaudhuri S; Klareskog L; Askling J
• Article: PLOS ONE. 2016;11(5):e0155956

  Prevalence of Periodontitis in Patients with Established Rheumatoid Arthritis: A Swedish Population Based Case-Control Study

  Eriksson K; Nise L; Kats A; Luttropp E; Catrina AI; Askling J; Jansson L; Alfredsson L; Klareskog L; Lundberg K; Yucel-Lindberg T
• Article: EUROPEAN HEART JOURNAL. 2015;36(48):3413-3422

  Rheumatoid arthritis is associated with a more severe presentation of acute coronary syndrome and worse short-term outcome

  Mantel A; Holmqvist M; Jernberg T; Wallberg-Jonsson S; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(12):2137-2143

  TNF inhibitor therapy and risk of breast cancer recurrence in patients with rheumatoid arthritis: a nationwide cohort study

  Raaschou P; Frisell T; Askling J
• Article: ARTHRITIS CARE AND RESEARCH. 2015;67(12):1637-1645

  Methodological Challenges When Comparing Demographic and Clinical Characteristics of International Observational Registries

  Verstappen SMM; Askling J; Berglind N; Franzen S; Frisell T; Garwood C; Greenberg JD; Holmqvist M; Horne L; Lampl K; Michaud K; Nyberg F; Pappas DA; Reed G; Symmons DPM; Tanaka E; Tran TN; Yamanaka H; Ho M
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(6):431-437

  Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register

  Chatzidionysiou K; Kristensen L-E; Eriksson J; Askling J; van Vollenhoven R
• Article: SCANDINAVIAN JOURNAL OF UROLOGY. 2015;49(6):486-491

  Surgical interventions for nephrolithiasis in ankylosing spondylitis and the general population

  Jakobsen AK; Jacobsson LTH; Patschan O; Hopfgarten T; Askling J; Kristensen LE
• Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(11):2845-2854

  Risk Factors for the Rapid Increase in Risk of Acute Coronary Events in Patients With New-Onset Rheumatoid Arthritis: A Nested Case-Control Study

  Mantel A; Holmqvist M; Nyberg F; Tornling G; Frisell T; Alfredsson L; Askling J
• Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2015;24(11):1121-1132

  Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach

  Nyberg F; Askling J; Berglind N; Franzen S; Ho M; Holmqvist M; Horne L; Lampl K; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SMM; Wesby-van Swaay E; Yamanaka H; Greenberg JD
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(5):369-376

  Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register

  Lindstrom U; Exarchou S; Sigurdardottir V; Sundstrom B; Askling J; Eriksson JK; Forsblad-d'Elia H; Turesson C; Kristensen LE; Jacobsson L
• Article: ARTHRITIS CARE AND RESEARCH. 2015;67(9):1219-1229

  Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and Registers

  Radner H; Dixon W; Hyrich K; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(8):1522-1529

  Improved performance of epidemiologic and genetic risk models for rheumatoid arthritis serologic phenotypes using family history

  Sparks JA; Chen C-Y; Jiang X; Askling J; Hiraki LT; Malspeis S; Klareskog L; Alfredsson L; Costenbader KH; Karlson EW
• Article: RHEUMATOLOGY. 2015;54(8):1472-1477

  Does disease activity at the start of biologic therapy influence health care costs in patients with RA?

  Johansson K; Eriksson JK; van Vollenhoven R; Miller H; Askling J; Neovius M
• Article: ARTHRITIS CARE AND RESEARCH. 2015;67(8):1137-1149

  Safety of Etoricoxib, Celecoxib, and Nonselective Nonsteroidal Antiinflammatory Drugs in Ankylosing Spondylitis and Other Spondyloarthritis Patients: A Swedish National Population-Based Cohort Study

  Kristensen LE; Jakobsen AK; Askling J; Nilsson F; Jacobsson LTH
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):1212-1217

  Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?

  Arkema EV; Jonsson J; Baecklund E; Bruchfeld J; Feltelius N; Askling J
• Article: RHEUMATOLOGY. 2015;54(6):1074-1079

  The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

  Kearsley-Fleet L; Zavada J; Hetland ML; Nordstroem DC; Aaltonen KJ; Listing J; Zink A; Gati T; Rojkovich B; Iannone F; Gremese E; van Riel PLCM; van de Laar MAFJ; Lie E; Kvien TK; Canhao H; Fonseca JE; Rotar Z; Loza E; Carmona L; Askling J; Johansson K; Finckh A; Dixon WG; Hyrich KL
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(6):970-978

  The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study

  Lie E; Kristensen LE; Forsblad-d'Elia H; Zverkova-Sandstrom T; Askling J; Jacobsson LT
• Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):118

  The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study

  Exarchou S; Lindstrom U; Askling J; Eriksson JK; Forsblad-d'Elia H; Neovius M; Turesson C; Kristensen LE; Jacobsson LTH
• Article: JOURNAL OF INTERNAL MEDICINE. 2015;277(5):594-604

  The autoimmune spectrum of myasthenia gravis: a Swedish population-based study

  Fang F; Sveinsson O; Thormar G; Granqvist M; Askling J; Lundberg IE; Ye W; Hammarstrom L; Pirskanen R; Piehl F
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(5):890-896

  Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register

  Chatzidionysiou K; Askling J; Eriksson J; Kristensen LE; van Vollenhoven R
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(4):648-654

  Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?

  Eriksson JK; Johansson K; Askling J; Neovius M
• Article: JOURNAL OF RHEUMATOLOGY. 2015;42(4):690-694

  Leukemia and Myelodysplastic Syndrome in Granulomatosis with Polyangiitis: Subtypes, Clinical Characteristics, and Outcome

  Knight A; Hjorton K; Sundstrom C; Hoglund M; Backlin C; Smedby KE; Askling J; Baecklund E
• Article: ARTHRITIS RESEARCH & THERAPY. 2015;17(1):40

  Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study

  Di Giuseppe D; Bottai M; Askling J; Wolk A
• Article: ARTHRITIS & RHEUMATOLOGY. 2015;67(2):352-362

  To What Extent Is the Familial Risk of Rheumatoid Arthritis Explained by Established Rheumatoid Arthritis Risk Factors?

  Jiang X; Frisell T; Askling J; Karlson EW; Klareskog L; Alfredsson L; Kallberg H
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(2):354-360

  Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab

  Neovius M; Arkema EV; Olsson H; Eriksson JK; Kristensen LE; Simard JF; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2015;74(2):375-380

  Environmental and genetic factors in the development of anticitrullinated protein antibodies (ACPAs) and ACPA-positive rheumatoid arthritis: an epidemiological investigation in twins

  Hensvold AH; Magnusson PKE; Joshua V; Hansson M; Israelsson L; Ferreira R; Jakobsson P-J; Holmdahl R; Hammarstrom L; Malmstrom V; Askling J; Klareskog L; Catrina AI
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2015;44(1):22-28

  How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?

  Wadstrom H; Eriksson JK; Neovius M; Askling J
• Article: BMC MUSCULOSKELETAL DISORDERS. 2014;15:432

  Validation of the rheumatoid arthritis diagnosis in the Swedish National patient register: a cohort study from Stockholm County

  Waldenlind K; Eriksson JK; Grewin B; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(11):1949-1953

  Long-term intake of dietary long-chain n-3 polyunsaturated fatty acids and risk of rheumatoid arthritis: a prospective cohort study of women

  Di Giuseppe D; Wallin A; Bottai M; Askling J; Wolk A
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(11):2061-2062

  No association between rheumatoid arthritis, amyotrophic lateral sclerosis, and tumour necrosis factor inhibitor treatment

  Arkema EV; Feltelius N; Olsson T; Askling J
• Article: SCHIZOPHRENIA BULLETIN. 2014;40(6):1552-1559

  The association between schizophrenia and rheumatoid arthritis: a nationwide population-based Swedish study on intraindividual and familial risks.

  Sellgren C; Frisell T; Lichtenstein P; Landèn M; Askling J
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2014;32(5 Suppl 85):S-147-9

  The Swedish Rheumatology Quality Register: optimisation of rheumatic disease assessments using register-enriched data.

  Eriksson JK; Askling J; Arkema EV
• Article: ARTHRITIS RESEARCH & THERAPY. 2014;16(3):R127

  The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study

  Ljung L; Askling J; Rantapaa-Dahlqvist S; Jacobsson L
• Article: BMC CANCER. 2014;14:391

  Aspirin intake and breast cancer survival - a nation-wide study using prospectively recorded data in Sweden

  Holmes MD; Olsson H; Pawitan Y; Holm J; Lundholm C; Andersson TM-L; Adami H-O; Askling J; Smedby KE
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(6):e32

  Response to: 'Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register)' by Iannone et al

  Neovius M; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(5):845-853

  Predictors of work disability during the first 3 years after diagnosis in a national rheumatoid arthritis inception cohort

  Olofsson T; Petersson IF; Eriksson JK; Englund M; Simard JF; Nilsson J-A; Geborek P; Jacobsson LTH; Askling J; Neovius M
• Article: ARTHRITIS & RHEUMATOLOGY. 2014;66(5):1282-1290

  Ankylosing Spondylitis, Psoriatic Arthritis, and Risk of Malignant Lymphoma A Cohort Study Based on Nationwide Prospectively Recorded Data From Sweden

  Hellgren K; Smedby KE; Backlin C; Sundstrom C; Feltelius N; Eriksson JK; Baecklund E; Askling J
• Letter: ANNALS OF THE RHEUMATIC DISEASES. 2014;73(3):628

  Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries

  Zavada J; Dixon WG; Askling J
• Article: JOURNAL OF INTERNAL MEDICINE. 2014;275(2):172-190

  Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up

  Persson I; Granath F; Askling J; Ludvigsson JF; Olsson T; Feltelius N
• Review: SEMINARS IN CANCER BIOLOGY. 2014;24:61-70

  Lymphoma development in patients with autoimmune and inflammatory disorders - What are the driving forces?

  Baecklund E; Smedby KE; Sutton L-A; Askling J; Rosenquist R
• Article: PLOS ONE. 2014;9(11):e113602

  Is Nephrolithiasis an Unrecognized Extra-Articular Manifestation in Ankylosing Spondylitis? A Prospective Population-Based Swedish National Cohort Study with Matched General Population Comparator Subjects

  Jakobsen AK; Jacobsson LTH; Patschan O; Askling J; Kristensen LE
• Article: ALIMENTARY PHARMACOLOGY AND THERAPEUTICS. 2014;39(1):57-68

  Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study

  Busch K; Ludvigsson JF; Ekstrom-Smedby K; Ekbom A; Askling J; Neovius M
• Article: ARTHRITIS & RHEUMATOLOGY. 2013;65(11):2773-2782

  Familial Risks and Heritability of Rheumatoid Arthritis Role of Rheumatoid Factor/Anti-Citrullinated Protein Antibody Status, Number and Type of Affected Relatives, Sex, and Age

  Frisell T; Holmqvist M; Kallberg H; Klareskog L; Alfredsson L; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(10):1675-1679

  Long-term work disability in patients with psoriatic arthritis treated with anti-tumour necrosis factor: a population-based regional Swedish cohort study

  Kristensen LE; Englund M; Neovius M; Askling J; Jacobsson LTH; Petersson IF
• Letter: ARTHRITIS & RHEUMATOLOGY. 2013;65(6):1671-1672

  Mortality rates among patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: comment on the article by Simard et al Reply

  Simard JF; Neovius M; Askling J
• Article: ARTHRITIS CARE AND RESEARCH. 2013;65(6):870-878

  Incidence of Rheumatoid Arthritis in Sweden: A Nationwide Population-Based Assessment of Incidence, Its Determinants, and Treatment Penetration

  Eriksson JK; Neovius M; Ernestam S; Lindblad S; Simard JF; Askling J
• Article: ARTHRITIS CARE AND RESEARCH. 2013;65(5):678-685

  Increased Risk of Arthropathies and Joint Replacement Surgery in Patients With Genetic Hemochromatosis: A Study of 3,531 Patients and Their 11,794 First-Degree Relatives

  Elmberg M; Hultcrantz R; Simard JF; Carlsson A; Askling J
• Article: ARTHRITIS RESEARCH & THERAPY. 2013;15(2):R56

  Cigarette smoking and smoking cessation in relation to risk of rheumatoid arthritis in women

  Di Giuseppe D; Orsini N; Alfredsson L; Askling J; Wolk A
• Article: THE BMJ. 2013;346:f1939

  Rheumatoid arthritis, anti-tumour necrosis factor therapy, and risk of malignant melanoma: nationwide population based prospective cohort study from Sweden

  Raaschou P; Simard JF; Holmqvist M; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2013;72(4):541-546

  Occurrence and relative risk of stroke in incident and prevalent contemporary rheumatoid arthritis

  Holmqvist M; Gransmark E; Mantel A; Alfredsson L; Jacobsson LTH; Wallberg-Jonsson S; Askling J
• Article: PLOS GENETICS. 2013;9(3):e1003394

  Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis

  Cui J; Stahl EA; Saevarsdottir S; Miceli C; Diogo D; Trynka G; Raj T; Mirkov MU; Canhao H; Ikari K; Terao C; Okada Y; Wedren S; Askling J; Yamanaka H; Momohara S; Taniguchi A; Ohmura K; Matsuda F; Mimori T; Gupta N; Kuchroo M; Morgan AW; Isaacs JD; Wilson AG; Hyrich KL; Herenius M; Doorenspleet ME; Tak P-P; Crusius JBA; van der Horst-Bruinsma IE; Wolbink GJ; van Riel PLCM; van de Laar M; Guchelaar H-J; Shadick NA; Allaart CF; Huizinga TWJ; Toes REM; Kimberly RP; Bridges SLJ; Criswell LA; Moreland LW; Fonseca JE; de Vries N; Stranger BE; De Jager PL; Raychaudhuri S; Weinblatt ME; Gregersen PK; Mariette X; Barton A; Padyukov L; Coenen MJH; Karlson EW; Plenge RM
• Article: LAKARTIDNINGEN. 2013;110(3):82-84

  [Observational cohort studies. Overview and some examples from the field of drug safety].

  Holmqvist M; Raaschou P; Neovius M; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(11):3502-3510

  Mortality Rates in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors Drug-Specific Comparisons in the Swedish Biologics Register

  Simard JF; Neovius M; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(11):1865-1867

  Incidence of progressive multifocal leukoencephalopathy in patients with rheumatoid arthritis: a national population-based study

  Arkema EV; van Vollenhoven RF; Askling J
• Article: JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (JAMA). 2012;308(13):1350-1356

  Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization

  Holmqvist ME; Neovius M; Eriksson J; Mantel A; Wallberg-Jonsson S; Jacobsson LTH; Askling J
• Article: JOURNAL OF RHEUMATOLOGY. 2012;39(8):1583-1602

  Canadian Rheumatology Association Recommendations for the Pharmacological Management of Rheumatoid Arthritis with Traditional and Biologic Disease-modifying Antirheumatic Drugs: Part II Safety

  Bombardier C; Hazlewood GS; Akhavan P; Schieir O; Dooley A; Haraoui B; Khraishi M; Leclercq SA; Legare J; Mosher DP; Pencharz J; Pope JE; Thomson J; Thorne C; Zummer M; Gardam MA; Askling J; Bykerk V
• Article: THE BMJ. 2012;345:e4230

  Long term alcohol intake and risk of rheumatoid arthritis in women: a population based cohort study

  Di Giuseppe D; Alfredsson L; Bottai M; Askling J; Wolk A
• Article: JOURNAL OF INTERNAL MEDICINE. 2012;272(1):45-54

  Risk of ischaemic heart disease and cardiomyopathy in patients with haemochromatosis and in their first-degree relatives: a nationwide, population-based study

  Elmberg M; Hultcrantz R; Simard JF; Stal P; Pehrsson K; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2012;64(1):42-52

  Treatment with tumor necrosis factor inhibitors and the risk of acute coronary syndromes in early rheumatoid arthritis

  Ljung L; Simard JF; Jacobsson L; Rantapaa-Dahlqvist S; Askling J
• Article: DIGESTIVE AND LIVER DISEASE. 2011;43(11):862-868

  Coeliac disease characteristics, compliance to a gluten free diet and risk of lymphoma by subtype

  Olen O; Askling J; Ludvigsson JF; Hildebrand H; Ekbom A; Smedby KE
• Letter: CIRCULATION. 2011;124(16):E423

  Response to Letter Regarding Article, "Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease"

  Ludvigsson JF; James S; Askling J; Ingelsson E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(8):1407-1414

  Sick leave and disability pension before and after initiation of antirheumatic therapies in clinical practice

  Neovius M; Simard JF; Klareskog L; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(7):1812-1822

  Does Cancer That Occurs During or After Anti-Tumor Necrosis Factor Therapy Have a Worse Prognosis? A National Assessment of Overall and Site-Specific Cancer Survival in Rheumatoid Arthritis Patients Treated With Biologic Agents

  Raaschou P; Simard JF; Neovius M; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(6):1010-1015

  How large are the productivity losses in contemporary patients with RA, and how soon in relation to diagnosis do they develop?

  Neovius M; Simard JF; Askling J
• Letter: LEUKEMIA AND LYMPHOMA. 2011;52(6):1146-1149

  LMO2 protein expression predicts survival in patients with rheumatoid arthritis and diffuse large B-cell lymphoma

  Baecklund E; Backlin C; Mansouri M; Klareskog L; Askling J; Iliadou AN; Enblad G; Lossos IS; Natkunam Y; Rosenquist R
• Article: INFLAMMATORY BOWEL DISEASES. 2011;17(5):1101-1107

  Colitis-associated DNA Aneuploidy and Dysplasia in Crohn's Disease and Risk of Colorectal Cancer

  Soderlund S; Tribukait B; Ost A; Brostrom O; Karlen P; Lofberg R; Askling J; Sjoqvist U
• Editorial comment: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(4):561-562

  Influence of biological agents on cardiovascular disease in rheumatoid arthritis

  Askling J; Dixon W
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(4):624-629

  Nationwide prevalence of rheumatoid arthritis and penetration of disease-modifying drugs in Sweden

  Neovius M; Simard JF; Askling J
• Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2011;103(5):436-444

  Risk of Lymphoproliferative Malignancy in Relation to Small Intestinal Histopathology Among Patients With Celiac Disease

  Elfstrom P; Granath F; Smedby KE; Montgomery SM; Askling J; Ekbom A; Ludvigsson JF
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(3):516-519

  Generalisability of clinical registers used for drug safety and comparative effectiveness research: coverage of the Swedish Biologics Register

  Neovius M; Simard JF; Sundstrom A; Jacobsson L; Geborek P; Saxne T; Feltelius N; Klareskog L; Askling J
• Article: CIRCULATION. 2011;123(5):483-U239

  Nationwide Cohort Study of Risk of Ischemic Heart Disease in Patients With Celiac Disease

  Ludvigsson JF; James S; Askling J; Stenestrand U; Ingelsson E
• Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2011;20(2):119-130

  Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data

  Askling J; Fahrbach K; Nordstrom B; Ross S; Schmid CH; Symmons D
• Article: RHEUMATOLOGY. 2011;50(1):204-213

  Ten years with biologics: to whom do data on effectiveness and safety apply?

  Simard JF; Arkema EV; Sundstrom A; Geborek P; Saxne T; Baecklund E; Coster L; Dackhammar C; Jacobsson L; Feltelius N; Lindblad S; Rantapaa-Dahlqvist S; Klareskog L; van Vollenhoven RF; Neovius M; Askling J
• Article: SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. 2011;40(1):8-15

  Small-area variations in sales of TNF inhibitors in Sweden between 2000 and 2009

  Neovius M; Sundstrom A; Simard JF; Wettermark B; Cars T; Feltelius N; Askling J; Klareskog L
• Article: ARTHRITIS & RHEUMATOLOGY. 2011;63(1):26-36

  Patients With Early Rheumatoid Arthritis Who Smoke Are Less Likely to Respond to Treatment With Methotrexate and Tumor Necrosis Factor Inhibitors Observations From the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register Cohorts

  Saevarsdottir S; Wedren S; Seddighzadeh M; Bengtsson C; Wesley A; Lindblad S; Askling J; Alfredsson L; Klareskog L
• Article: RHEUMATOLOGY. 2011;50(1):146-151

  Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers

  Strangfeld A; Hyrich K; Askling J; Arkema E; Davies R; Listing J; Neovius M; Simard J; Symmons D; Watson K; Zink A
• Article: JOURNAL OF RHEUMATOLOGY. 2010;37(12):2553-2558

  Increased Risk of Autoimmune Disease in Families with Wegener's Granulomatosis

  Knight A; Sandin S; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(12):3776-3782

  Juvenile Idiopathic Arthritis and Risk of Cancer A Nationwide Cohort Study

  Simard JF; Neovius M; Hagelberg S; Askling J
• Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(6):578-585

  Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006

  Holmqvist ME; Wedren S; Jacobsson LTH; Klareskog L; Nyberg F; Rantapaa-Dahlqvist S; Alfredsson L; Askling J
• Review: ZEITSCHRIFT FUR RHEUMATOLOGIE. 2010;69(9):774-779

  The risk of malignancies in RA patients treated with biologics

  Askling J
• Article: JOURNAL OF INTERNAL MEDICINE. 2010;268(4):329-337

  Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study

  Norgaard M; Larsson H; Pedersen L; Granath F; Askling J; Kieler H; Ekbom A; Sorensen HT; Stephansson O
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(9):1596-1602

  EULAR points to consider when establishing, analysing and reporting safety data of biologics registers in rheumatology

  Dixon WG; Carmona L; Finckh A; Hetland ML; Kvien TK; Landewe R; Listing J; Nicola PJ; Tarp U; Zink A; Askling J
• Review: SEMINARS IN ARTHRITIS AND RHEUMATISM. 2010;40(1):2-14.e1

  A Comparison of Patient Characteristics and Outcomes in Selected European and US Rheumatoid Arthritis Registries

  Curtis JR; Jain A; Askling J; Bridges SLJ; Carmona L; Dixon W; Finckh A; Hyrich K; Greenberg JD; Kremer J; Listing J; Michaud K; Mikuls T; Shadick N; Solomon DH; Weinblatt ME; Wolfe F; Zink A
• Letter: ARTHRITIS & RHEUMATOLOGY. 2010;62(8):2561

  Ischemic heart disease and rheumatoid arthritis: comment on the article by Holmqvist et al Reply

  Holmqvist M; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(7):1849-1861

  Rheumatoid Arthritis Risk Allele PTPRC Is Also Associated With Response to Anti-Tumor Necrosis Factor α Therapy

  Cui J; Saevarsdottir S; Thomson B; Padyukov L; van der Helm-van Mil AHM; Nititham J; Hughes LB; de Vries N; Raychaudhuri S; Alfredsson L; Askling J; Wedren S; Ding B; Guiducci C; Wolbink GJ; Crusius JBA; van der Horst-Bruinsma IE; Herenius M; Weinblatt ME; Shadick NA; Worthington J; Batliwalla F; Kern M; Morgan AW; Wilson AG; Isaacs JD; Hyrich K; Seldin MF; Moreland LW; Behrens TW; Allaart CF; Criswell LA; Huizinga TWJ; Tak PP; Bridges SLJ; Toes REM; Barton A; Klareskog L; Gregersen PK; Karlson EW; Plenge RM
• Article: JOURNAL OF CYSTIC FIBROSIS. 2010;9(4):288-291

  Cystic fibrosis gene mutations and gastrointestinal diseases

  Bahmanyar S; Ekbom A; Askling J; Johannesson M; Montgomery SM
• Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2010;181(11):1217-1222

  Smoking, Use of Moist Snuff, and Risk of Chronic Inflammatory Diseases

  Carlens C; Hergens M-P; Grunewald J; Ekbom A; Eklund A; Hoglund CO; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2010;62(5):1252-1258

  Do Rheumatoid Arthritis and Lymphoma Share Risk Factors? A Comparison of Lymphoma and Cancer Risks Before and After Diagnosis of Rheumatoid Arthritis

  Hellgren K; Smedby KE; Feltelius N; Baecklund E; Askling J
• Article: GASTROENTEROLOGY. 2010;138(5):1697-1703

  Inflammatory Bowel Disease Confers a Lower Risk of Colorectal Cancer to Females Than to Males

  Soderlund S; Granath F; Brostrom O; Karlen P; Lofberg R; Ekbom A; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(4):654-659

  Rheumatoid arthritis, treatment with corticosteroids and risk of malignant lymphomas: results from a case-control study

  Hellgren K; Iliadou A; Rosenquist R; Feltelius N; Backlin C; Enblad G; Askling J; Baecklund E
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2010;69(4):737-740

  Occupational risk factors for Wegener's granulomatosis: a case-control study

  Knight A; Sandin S; Askling J
• Article: HEPATOLOGY. 2010;51(2):595-602

  Decreased Survival of Subjects with Elevated Liver Function Tests During a 28-Year Follow-Up

  Soderberg C; Stal P; Askling J; Glaumann H; Lindberg G; Marmur J; Hultcrantz R
• Article: ARTHRITIS RESEARCH & THERAPY. 2010;12(2):R67

  Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment

  Simon TA; Askling J; Lacaille D; Franklin J; Wolfe F; Covucci A; Suissa S; Hochberg MC
• Article: INTERNATIONAL JOURNAL OF CANCER. 2009;125(12):2953-2956

  Cancer risk among patients with cystic fibrosis and their first-degree relatives

  Johannesson M; Askling J; Montgomery SM; Ekbom A; Bahmanyar S
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(12):1819-1826

  Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment

  Simon TA; Smitten AL; Franklin J; Askling J; Lacaille D; Wolfe F; Hochberg MC; Qi K; Suissa S
• Letter: GASTROENTEROLOGY. 2009;137(5):1858

  Is Ulcerative Colitis Proctitis Associated With an Increased Risk of Colorectal Cancer? Reply

  Soderlund S; Brandt L; Lapidus A; Karlen P; Brostrom O; Lofberg R; Ekbom A; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(11):3180-3189

  Cancer Risk in Patients With Rheumatoid Arthritis Treated With Anti-Tumor Necrosis Factor α Therapies Does the Risk Change With the Time Since Start of Treatment?

  Askling J; van Vollenhoven RF; Granath F; Raaschou P; Fored CM; Baecklund E; Dackhammar C; Feltelius N; Coster L; Geborek P; Jacobsson LT; Lindblad S; Rantapaa-Dahlqvist S; Saxne T; Klareskog L
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(10):2861-2869

  No Increased Occurrence of Ischemic Heart Disease Prior to the Onset of Rheumatoid Arthritis Results From Two Swedish Population-Based Rheumatoid Arthritis Cohorts

  Holmqvist ME; Wedren S; Jacobsson LTH; Klareskog L; Nyberg F; Rantapaa-Dahlqvist S; Alfredsson L; Askling J
• Article: GASTROENTEROLOGY. 2009;137(4):1301-1309

  Increased Mortality Risk in Patients With Phenotypic Hereditary Hemochromatosis But Not in Their First-Degree Relatives

  Elmberg M; Hultcrantz R; Ebrahim F; Olsson S; Lindgren S; Loof L; Stal P; Wallerstedt S; Almer S; Sandberg-Gertzen H; Ekbom A; Askling J
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(8):1240-1246

  European biologicals registers: methodology, selected results and perspectives

  Zink A; Askling J; Dixon WG; Klareskog L; Silman AJ; Symmons DPM
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(7):1159-1164

  Perinatal characteristics, early life infections and later risk of rheumatoid arthritis and juvenile idiopathic arthritis

  Carlens C; Jacobsson L; Brandt L; Cnattingius S; Stephansson O; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2009;68(5):648-653

  Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register

  Askling J; Baecklund E; Granath F; Geborek P; Fored M; Backlin C; Bertilsson L; Coster L; Jacobsson LT; Lindblad S; Lysholm J; Rantapaa-Dahlqvist S; Saxne T; van Vollenhoven R; Klareskog L; Feltelius N
• Article: GASTROENTEROLOGY. 2009;136(5):1561-1567

  Decreasing Time-Trends of Colorectal Cancer in a Large Cohort of Patients With Inflammatory Bowel Disease

  Soderlund S; Brandt L; Lapidus A; Karlen P; Brostrom O; Lofberg R; Ekbom A; Askling J
• Article: MULTIPLE SCLEROSIS JOURNAL. 2009;15(4):431-436

  Effects of infectious mononucleosis and HLA-DRB1*15 in multiple sclerosis

  Nielsen TR; Rostgaard K; Askling J; Steffensen R; Oturai A; Jersild C; Koch-Henriksen N; Sorensen PS; Hjalgrim H
• Article: ARTHRITIS & RHEUMATOLOGY. 2009;60(3):653-660

  Specific Association of Type 1 Diabetes Mellitus With Anti-Cyclic Citrullinated Peptide-Positive Rheumatoid Arthritis

  Liao KP; Gunnarsson M; Kallberg H; Ding B; Plenge RM; Padyukov L; Karlson EW; Klareskog L; Askling J; Alfredsson L
• Review: JOURNAL OF INTERNAL MEDICINE. 2008;264(6):514-527

  Autoimmune and inflammatory disorders and risk of malignant lymphomas - an update

  Smedby KE; Askling J; Mariette X; Baecklund E
• Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2008;6(8):939-943

  Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis

  Bergquist A; Montgomery SM; Bahmanyar S; Olsson R; Danielsson A; Lindgren S; Prytz H; Hultcrantz R; Loof L; Sandberg-Gertzen H; Almer S; Askling J; Ehlin A; Ekbom A
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2008;43(8):961-966

  Early-life exposures associated with antibiotic use and risk of subsequent Crohn's disease

  Hildebrand H; Malmborg P; Askling J; Ekbom A; Montgomery SM
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2008;26(3):S53-S56

  What is the significance in routine care of c-ANCA/PR3-ANCA in the absence of systemic vasculitis? A case series

  Knight A; Ekbom A; Brandt L; Askling J
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2008;20(3):334-339

  Malignancy and biologic therapy in rheumatoid arthritis

  Askling J; Bongartz T
• Article: BRITISH JOURNAL OF HAEMATOLOGY. 2008;141(1):69-72

  Expression of the human germinal-centre-associated lymphoma protein in diffuse large B-cell lymphomas in patients with rheumatoid arthritis

  Baecklund E; Natkunam Y; Backlin C; Iliadou A; Askling J; Ekbom A; Feltelius N; Klareskog L; Enblad G; Lossos IS; Levy R; Sundstroem C; Rosenquist R
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2008;20(2):138-144

  The safety of anti-tumour necrosis factor therapy in rheumatoid arthritis

  Askling J; Dixon W
• Article: ARTHRITIS & RHEUMATOLOGY. 2008;58(1):302-307

  Risks and relative risks of Wegener's granulomatosis among close relatives of patients with the disease

  Knight A; Sandin S; Askling J
• Review: CURRENT RHEUMATOLOGY REPORTS. 2007;9(5):421-426

  Malignancy and rheumatoid arthritis.

  Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(10):1339-1344

  Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists

  Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelius N; Coster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapaa-Dahlqvist S; Saxne T; van Vollenhoven RF; Klareskog L
• Article: EUROPEAN RESPIRATORY JOURNAL. 2007;30(3):414-422

  Influenza vaccination and mortality:: prospective cohort study of the elderly in a large geographical area

  Oertqvist A; Granath F; Askling J; Hedlund J
• Article: INFLAMMATORY BOWEL DISEASES. 2007;13(5):531-536

  Potential role for the common cystic fibrosis AF508 mutation in Crohn's disease

  Bresso F; Askling J; Astegiano M; Demarchi B; Sapone N; Rizzetto M; Gionchetti P; Lammers KM; de Leone A; Riegler G; Nimmo ER; Drummond H; Noble C; Torkvist L; Ekbom A; Zucchelli M; Lofberg R; Satsangi J; Pettersson S; D'Amato M
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2007;66(3):414-416

  The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy

  Carlens C; Brandt L; Klareskog L; Lampa J; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(12):3774-3781

  Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis

  Baecklund E; Backlin C; Iliadou A; Granath F; Ekbom A; Amini R-M; Feltelius N; Enblad G; Sundstrom C; Klareskog L; Askling J; Rosenquist R
• Article: DIGESTIVE AND LIVER DISEASE. 2006;38(11):823-828

  Diagnosis underlying appendectomy and coeliac disease risk

  Ludvigsson JF; Askling J; Ekbom A; Montgomery SM
• Review: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2006;15(11):2069-2077

  Malignant lymphomas in autoimmunity and inflammation: A review of risks, risk factors, and lymphoma characteristics

  Ekstrom Smedby K; Baecklund E; Askling J
• Article: JOURNAL OF RHEUMATOLOGY. 2006;33(10):2060-2063

  Increasing incidence of Wegener's granulomatosis in Sweden, 1975-2001

  Knight A; Ekbom A; Brandt L; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(9):1184-1187

  Risk for malignant lymphoma in ankylosing spondylitis: a nationwide Swedish case-control study

  Askling J; Klareskog L; Blomqvist P; Fored M; Feltelius N
• Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2006;15(7):1295-1300

  Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was

  Sandin S; Hjalgrim H; Glimelius B; Rostgaard K; Pukkala E; Askling J
• Review: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(6):707-712

  Swedish registers to examine drug safety and clinical issues in RA

  Askling J; Fored CM; Geborek P; Jacobsson LTH; van Vollenhoven R; Feltelius N; Lindblad S; Klareskog L
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2006;65(6):741-745

  Impact of parental history on patients' cardiovascular mortality in rheumatoid arthritis

  Björnådal L; Brandt L; Klareskog L; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2006;54(3):692-701

  Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

  Baecklund E; Iliadou A; Askling J; Ekborn A; Backlin C; Granath F; Catrina AT; Rosenquist R; Feltelius N; Sundström C; Klareskog L
• Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(2):449-452

  Personal and family history of autoimmune diabetes mellitus and susceptibility to young-adult-onset Hodgkin lymphoma

  Landgren O; Björkholm M; Montgomery SM; Hjalgrim H; Sjöberg J; Goldin LR; Askling J
• Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2006;98(1):51-60

  Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

  Smedby KE; Hjalgrim H; Askling J; T Chang E; Gregersen H; Porwit-MacDonald A; Sundström C; Åkerman M; Melbye M; Glimelius B; Adami HO
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(12):1765-1768

  Do steroids increase lymphoma risk?: A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis

  Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(10):1414-1420

  Haematopoietic malignancies in rheumatoid arthritis:: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

  Askling J; Fored CM; Baecklund E; Brandt L; Backlin C; Ekbom A; Sundström C; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L; Feltelius N
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2005;64(10):1421-1426

  Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

  Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Feltelus N; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Klareskog L
• Article: CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2005;23(5):S195-S200

  Rheumatoid arthritis registries in Sweden

  van Vollenhoven RF; Askling J
• Article: ARTHRITIS & RHEUMATOLOGY. 2005;52(7):1986-1992

  Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden

  Askling J; Fored CM; Brandt L; Baecklund E; Bertilsson L; Cöster L; Geborek P; Jacobsson LT; Lindblad S; Lysholm J; Rantapää-Dahlqvist S; Saxne T; Romanus V; Klareskog L; Feltelius N
• Article: GUT. 2005;54(5):617-622

  Risk of haematopoietic cancer in patients with inflammatory bowel disease

  Askling J; Brandt L; Lapidus A; Karlén P; Björkholm M; Löfberg R; Ekbom A
• Article: GUT. 2005;54(1):54-59

  Malignant lymphomas in coeliac disease:: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma

  Smedby KE; Åkerman M; Hildebrand H; Glimelius B; Ekbom A; Askling J
• Article: ANNALS OF THE RHEUMATIC DISEASES. 2004;63(10):1307-1311

  Urinary bladder cancer in Wegener's granulomatosis: risks and relation to cyclophosphamide

  Knight A; Askling J; Granath F; Sparen P; Ekbom A
• Article: INTERNATIONAL JOURNAL OF CANCER. 2004;110(5):763-766

  Maternal breast cancer risk after the death of a child

  Lambe M; Cerrato R; Askling J; Hsieh CC
• Article: INTERNATIONAL JOURNAL OF CANCER. 2004;109(6):941-944

  Women smoking and testicular cancer: One epidemic causing another?

  Pettersson A; Kaijser M; Richiardi L; Askling J; Ekbom A; Akre O
• Review: CURRENT OPINION IN RHEUMATOLOGY. 2004;16(3):254-261

  Rheumatoid arthritis and malignant lymphomas

  Baecklund E; Askling J; Rosenquist R; Ekbom A; Klareskog L
• Article: ACTA ONCOLOGICA. 2004;43(3):297-301

  Parental longevity and prognosis in elderly patients with aggressive non-Hodgkin's lymphoma

  Ösby E; Askling J; Landgren O; Dickman PW; Ekbom A; Björkholm M
• Article: GASTROENTEROLOGY. 2003;125(6):1733-1741

  Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives

  Elmberg M; Hultcrantz R; Ekbom A; Brandt L; Olsson S; Olsson R; Lindgren S; Lööf L; Stål P; Wallerstedt S; Almer S; Sandberg-Gertzén H; Askling J
• Article: NEW ENGLAND JOURNAL OF MEDICINE. 2003;349(14):1324-1332

  Characteristics of Hodgkin's lymphoma after infectious mononucleosis

  Hjalgrim H; Askling J; Rostgaard K; Hamilton-Dutoit S; Frisch M; Zhang J; Madsen M; Rosdahl N; Konradsen HB; Storm HH; Melbye M
• Article: GUT. 2003;52(10):1432-1434

  Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001.

  Hildebrand H; Finkel Y; Grahnquist L; Lindholm J; Ekbom A; Askling J
• Article: ARCHIVES OF INTERNAL MEDICINE (CHICAGO, ILL. : 1908). 2003;163(13):1566-1572

  Causes of death in patients with celiac disease in a population-based Swedish cohort

  Peters U; Askling J; Gridley G; Ekbom A; Linet M
• Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2003;12(7):669-673

  Body size at birth and adulthood and the risk for germ-cell testicular cancer

  Richiardi L; Askling J; Granath F; Akre O
• Article: PEDIATRICS. 2003;111(6):1343-1350

  Appendectomy during childhood and adolescence and the subsequent risk of cancer in Sweden

  Cope JU; Askling J; Gridley G; Mohr A; Ekbom A; Nyren O; Linet MS
• Article: THE BMJ. 2003;326(7398):1068-1069

  Perinatal characteristics and risk of rheumatoid arthritis

  Jacobsson LTH; Jacobsson ME; Askling J; Knowler WC
• Article: ARTHRITIS & RHEUMATOLOGY. 2003;48(4):963-970

  Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives

  Ekström K; Hjalgrim H; Brandt L; Baecklund E; Klareskog L; Ekbom A; Askling J
• Article: GASTROENTEROLOGY. 2002;123(5):1428-1435

  Cancer incidence in a population-based cohort of individuals hospitalized with Celiac disease or dermatitis herpetiformis

  Askling J; Linet M; Gridley G; Halstensen TS; Ekström K; Ekbom A
• Article: INTERNATIONAL JOURNAL OF CANCER. 2002;100(1):82-85

  Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis

  Knight A; Askling J; Ekbom A
• Article: HAEMATOLOGICA. 2002;87(6):596-601

  Parental longevity and survival in elderly patients with Hodgkin's lymphoma

  Landgren O; Askling J; Dickman PW; Ösby E; Axdorph U; Ekbom A; Björkholm M
• Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2002;94(9):678-681

  Hematopoietic and lymphatic cancers in relatives of patients with infectious mononucleosis

  Hjalgrim H; Rostgaard K; Askling J; Madsen M; Storm HH; Rabkin CS; Melbye M
• Article: THE LANCET. 2001;358(9278):297-298

  Incidence of Hodgkin's disease in Nordic countries

  Hjalgrim H; Askling J; Pukkala E; Hansen S; Munksgaard L; Frisch M
• Article: GASTROENTEROLOGY. 2001;120(6):1356-1362

  Family history as a risk factor for colorectal cancer in inflammatory bowel disease

  Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
• Thesis / dissertation: 2001

  Epidemiological studies of host susceptibility in malignant lymphomas and colorectal cancer

  Askling, Johan
• Article: THE LANCET. 2001;357(9252):262-266

  Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease:: a population-based cohort study

  Askling J; Dickman PW; Karlén P; Broström O; Lapidus A; Löfberg R; Ekbom A
• Article: BRITISH JOURNAL OF CANCER. 2001;84(1):113-115

  Risk of non-Hodgkin's lymphoma following tuberculosis

  Askling J; Ekbom A
• Article: JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2000;92(18):1522-1528

  Risk of Hodgkin's disease and other cancers after infectious mononucleosis

  Hjalgrim H; Askling J; Sorensen P; Madsen M; Rosdahl N; Storm HH; Hamilton-Dutoit S; Eriksen LS; Frisch M; Ekbom A; Melbye M
• Article: THE LANCET. 1999;354(9195):2053

  Sickness in pregnancy and sex of child

  Askling J; Erlandsson G; Kaijser M; Akre O; Ekbom A
• Article: ANNALS OF INTERNAL MEDICINE. 1999;131(9):655-659

  Is history of squamous-cell skin cancer a marker of poor prognosis in patients with cancer?

  Askling J; Sorensen P; Ekbom A; Frisch M; Melbye M; Glimelius B; Hjalgrim H
• Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 1999;160(5):1668-1672

  Increased risk for cancer following sarcoidosis

  Askling J; Grunewald J; Eklund A; Hillerdal G; Ekbom A
• Article: THE LANCET. 1999;354(9185):1179

  Incidence of paediatric Crohn's disease in Stockholm, Sweden

  Askling J; Grahnquist L; Ekbom A; Finkel Y
• Show more

Staff and contact

Group leader

• 

  Johan Askling

  Professor/Senior Physician | Docent

  Telephone +46852483348

  E-mail johan.askling@ki.se

All members of the group

• 

  Peter Alping

  Postdoctoral Researcher

  Telephone +46852483226

  E-mail peter.alping@ki.se
• Pernilla Appelquist

  Administrator

  Telephone +46852483342

  E-mail pernilla.appelquist@ki.se
• 

  Elizabeth Arkema

  Principal Researcher | Docent

  E-mail elizabeth.arkema@ki.se
• 

  Johan Askling

  Professor/Senior Physician | Docent

  Telephone +46852483348

  E-mail johan.askling@ki.se
• 

  Majd Bairkdar

  Phd Student

  E-mail majd.bairkdar@ki.se
• 

  Magnus Boman

  Professor

  Telephone +46852481559

  E-mail magnus.boman@ki.se
• 

  Hannah Bower

  Affiliated to Research

  Telephone +46852482492

  E-mail hannah.bower@ki.se
• 

  Gustaf Bruze

  Research Coordinator

  E-mail gustaf.bruze@ki.se
• 

  Weng Ian Che

  Affiliated to Research

  E-mail weng.che@ki.se
• 

  Marina Dehara

  Project Coordinator

  E-mail marina.dehara@ki.se
• 

  Bénédicte Delcoigne

  Statistician

  E-mail benedicte.delcoigne@ki.se
• Edit Ekström

  Project Coordinator

  Telephone +46852487499

  E-mail edit.ekstrom@ki.se
• 

  Arvid Engström

  Phd Student

  E-mail arvid.engstrom@ki.se
• 

  Thomas Frisell

  Principal Researcher | Docent

  E-mail thomas.frisell@ki.se
• 

  Karin Gunnarsson

  Phd Student

  E-mail karin.gunnarsson@ki.se
• 

  Karin Hellgren

  Affiliated to Research

  E-mail karin.hellgren@ki.se
• 

  Marie Holmqvist

  Principal Researcher | Docent

  E-mail marie.holmqvist@ki.se
• Viking Huss

  Phd Student

  E-mail viking.huss@ki.se
• 

  Martina Johannesson

  Project Coordinator

  Telephone +46852483213

  E-mail martina.johannesson@ki.se
• 

  Paulina Jonéus

  Postdoctoral Researcher

  E-mail paulina.joneus@ki.se
• Ingvar Krakau

  Affiliated to Research | Docent

  E-mail ingvar.krakau@ki.se
• Younes Laalou

  Phd Student

  E-mail younes.laalou@ki.se
• 

  Carl-Emil Lim

  Phd Student

  E-mail carlemil.lim@ki.se
• Lotta Ljung

  Affiliated to Research

  E-mail lotta.ljung@ki.se
• Kinda Lundström

  Phd Student

  E-mail kinda.lundstrom@ki.se
• 

  Heather Miller

  Clinical Assistant

  E-mail heather.miller@ki.se
• 

  Viktor Molander

  Phd Student

  E-mail viktor.molander@ki.se
• 

  Martin Neovius

  Professor | Docent

  Telephone +46852482538

  E-mail martin.neovius@ki.se
• Viet Ngoc Nguyen

  Phd Student

  E-mail viet.ngoc.nguyen@ki.se
• 

  Helena Nord

  HR Administrator

  Telephone +46852483347

  E-mail helena.nord@ki.se
• Ida Palmqvist

  Project Assistant

  Telephone +46852487472

  E-mail ida.palmqvist@ki.se
• 

  Björn Pasternak

  Principal Researcher | Docent

  E-mail bjorn.pasternak@ki.se
• Karina Patasova

  E-mail karina.patasova@ki.se
• 

  Laura Pazzagli

  Research Specialist

  E-mail laura.pazzagli@ki.se
• Gunnar Petersson

  Software Programmer

  Telephone +46852483345

  E-mail gunnar.petersson@ki.se
• 

  Maxime Raffray

  Postdoctoral Researcher

  E-mail maxime.raffray@ki.se
• Maud Rutting

  Research Nurse

  E-mail maud.rutting@ki.se
• 

  Saedis Saevarsdottir

  Researcher | Docent

  E-mail saedis.saevarsdottir@ki.se
• Elina Salonen

  Phd Student

  E-mail elina.salonen@ki.se
• 

  Simon Steiger

  Statistician

  E-mail simon.steiger@ki.se
• Henrik Svanström

  Affiliated to Research

  E-mail henrik.svanstrom@ki.se
• 

  Liselotte Tidblad

  Affiliated to Research

  E-mail liselotte.tidblad@ki.se
• 

  Peter Ueda

  Assistant Professor | Docent

  E-mail peter.ueda@ki.se
• Suvi Virtanen

  Project Coordinator | Phd Student

  Telephone +46852483217

  E-mail suvi.virtanen@ki.se
• Hjalmar Wadström

  Affiliated to Research

  E-mail hjalmar.wadstrom@ki.se
• Karin Wadström

  Postdoctoral Studies

  E-mail karin.wadstrom@ki.se
• 

  Kristin Waldenlind

  Affiliated to Research

  E-mail kristin.waldenlind@ki.se
• Sara Wedrén

  Affiliated to Research

  E-mail sara.wedren@ki.se
• 

  Helga Westerlind

  Senior Research Specialist | Docent

  Telephone +46852483354

  E-mail helga.westerlind@ki.se
• Anna-Maria Wintler

  Phd Student

  E-mail anna-maria.wintler@ki.se
• 

  Viktor Wintzell

  Coordinator

  E-mail viktor.wintzell@ki.se
• 

  Daniela di Giuseppe

  Statistician | Docent

  E-mail daniela.digiuseppe@ki.se
• 

  Anton Öberg Sysojev

  E-mail anton.oberg.sysojev@ki.se
• 

  Caroline Öfverberg Colliander

  Project Coordinator

  Telephone +46852487439

  E-mail caroline.ofverberg@ki.se